CA2341704C - Three dimensional, low friction vasoocclusive coil, and method of manufacture - Google Patents
Three dimensional, low friction vasoocclusive coil, and method of manufacture Download PDFInfo
- Publication number
- CA2341704C CA2341704C CA002341704A CA2341704A CA2341704C CA 2341704 C CA2341704 C CA 2341704C CA 002341704 A CA002341704 A CA 002341704A CA 2341704 A CA2341704 A CA 2341704A CA 2341704 C CA2341704 C CA 2341704C
- Authority
- CA
- Canada
- Prior art keywords
- vasoocclusive
- vasoocclusive device
- vasculature
- cable
- strands
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 9
- 238000000034 method Methods 0.000 title claims description 18
- 210000005166 vasculature Anatomy 0.000 claims abstract description 70
- 239000000463 material Substances 0.000 claims abstract description 19
- 238000003780 insertion Methods 0.000 claims abstract description 14
- 230000037431 insertion Effects 0.000 claims abstract description 14
- 230000003014 reinforcing effect Effects 0.000 claims abstract description 7
- 239000002131 composite material Substances 0.000 claims description 23
- 239000012781 shape memory material Substances 0.000 claims description 22
- 238000004804 winding Methods 0.000 claims description 17
- 238000002560 therapeutic procedure Methods 0.000 claims description 16
- 238000007631 vascular surgery Methods 0.000 claims description 16
- 238000010438 heat treatment Methods 0.000 claims description 14
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 11
- 239000012858 resilient material Substances 0.000 claims description 8
- 229910045601 alloy Inorganic materials 0.000 claims description 7
- 239000000956 alloy Substances 0.000 claims description 7
- 238000005452 bending Methods 0.000 claims description 7
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 7
- 239000003550 marker Substances 0.000 claims description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 5
- 229910052737 gold Inorganic materials 0.000 claims description 5
- 239000010931 gold Substances 0.000 claims description 5
- 229910052697 platinum Inorganic materials 0.000 claims description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 4
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 claims description 4
- 229910052721 tungsten Inorganic materials 0.000 claims description 4
- 239000010937 tungsten Substances 0.000 claims description 4
- 229910052802 copper Inorganic materials 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 239000011819 refractory material Substances 0.000 claims description 3
- 238000007493 shaping process Methods 0.000 claims description 3
- 238000005482 strain hardening Methods 0.000 claims description 3
- 239000004033 plastic Substances 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- 229910000881 Cu alloy Inorganic materials 0.000 claims 1
- 239000013013 elastic material Substances 0.000 claims 1
- 229920002313 fluoropolymer Polymers 0.000 claims 1
- 239000004811 fluoropolymer Substances 0.000 claims 1
- 239000002783 friction material Substances 0.000 claims 1
- 229920000431 shape-memory polymer Polymers 0.000 claims 1
- 206010052428 Wound Diseases 0.000 description 19
- 208000027418 Wounds and injury Diseases 0.000 description 19
- 238000011282 treatment Methods 0.000 description 12
- 206010002329 Aneurysm Diseases 0.000 description 11
- 238000010276 construction Methods 0.000 description 10
- 230000008901 benefit Effects 0.000 description 8
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 238000013461 design Methods 0.000 description 3
- 239000013307 optical fiber Substances 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 208000005189 Embolism Diseases 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 206010016717 Fistula Diseases 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910000416 bismuth oxide Inorganic materials 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- TYIXMATWDRGMPF-UHFFFAOYSA-N dibismuth;oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Bi+3].[Bi+3] TYIXMATWDRGMPF-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000012634 optical imaging Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000001931 thermography Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000012285 ultrasound imaging Methods 0.000 description 1
- 230000007556 vascular defect Effects 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
- A61B17/12145—Coils or wires having a pre-set deployed three-dimensional shape
Abstract
The three dimensional, low friction vasoocclusive coil (1) has a distal portion (8') that is three dimensionally shaped, and a proximal portion (9') that is linear or helically shaped. The distal three dimensional portion (8') will form a basket for filling the anatomical cavity at the site in the vasculature to be treated, while the proximal portion (9') will fill and reinforce the basket. The vasoocclusive device (1) is formed from at least one strand of a flexible material formed to have a first inoperable, substantially linear configuration for insertion into and through a catheter or cannula to a desired portion of the vasculature to be treated, and a second operable, three dimensional configuration for occluding the desired portion of the vasculature to be treated. The vasoocclusive device (1) has a distal portion (8') having a second operable, three dimensional shape for filling the anatomical cavity at the site in the vasculature to be treated, and a proximal portion (9') having a second operable, substantially linear shape for filling and reinforcing the distal, three dimensional shaped portion when it is implanted at the site in the vasculature to be treated. Mandrels are provided for use in the method of making the vasoocclusive device.
Description
THREE DIMENSIONAL, LOW FRICTION VASOOCCLUSIVE COIL, AND METHOD OF MANUFACTURE
BACKGROUND OF THE INVENTION
Field of the Invention:
This invention relates generally to vasoocclusive devices, and more particularly concerns a vasoocclusive device that has a first elongated, reduced friction configuration in which the vasoocclusive device may be deployed through a catheter or cannula to an anatomical cavity at a site in the vasculature to be treated, and that has a three dimensional second configuration assumed by the vasoocclusive device at the site to be treated for filling the anatomical cavity.
Description of Related Art:
The art and science of interventional therapy and surgery has continually progressed towards treatment of internal defects and diseases by use of ever smaller incisions or access through the vasculature or body openings in order to reduce the trauma to tissue surrounding the treatment site. One important aspect of such treatments involves the use of catheters to place therapeutic devices at a treatment site by access through the vasculature. Examples of such procedures include transluminal angioplasty, placement of stents to reinforce the walls of a blood 148121.1 vessel or the like and the use of vasoocclusive devices to treat defects in the vasculature. There is a constant drive by those practicing in the art to develop new and more capable systems for such applications. When coupled with developments in biological treatment capabilities, there is an expanding need for technologies that enhance the performance of interventional therapeutic devices and systems.
One specific field of interventional therapy that has been able to advantageously use recent developments in technology is the treatment of neurovascular defects. More specifically, as smaller and more capable structures and materials have been developed, treatment of vascular defects in the human brain which were previously untreatable or represented unacceptable risks via conventional surgery have become amenable to treatment. One type of non-surgical therapy that has become advantageous for the treatment of defects in the neurovasculature has been the placement by way of a catheter of vasoocclusive devices in a damaged portion of a vein or artery.
Vasoocclusion devices are therapeutic devices that are placed within the vasculature of the human body, typically via a catheter, either to block the flow of blood through a vessel making up that portion of the vasculature through the formation of an embolus or to form such an embolus within an aneurysm stemming from the vessel. The vasoocclusive devices can take a variety of configurations, and are generally formed of one or more elements that are larger in the deployed configuration than when they are within the delivery catheter prior to placement. One widely used vasoocclusive device is a helical wire coil having a deployed configuration which mav be dimensioned to engage the walls of the vessels. One anatomically shaped vasoocclusive device that forms itself into a shape of an anatomical cavity such as an aneurysm and is made of a pre-fortned strand of flexible material that can be anickel-titanium alloy is kno,,Arn from U.S. Patent No.
5,645,558.
That vasoocclusive device comprises one or more vasoocciusive members wound to form a generally spherical or ovoid shape in a relaxed state. The vasoocclusive members can be a helically wound coil or a co-woven braid formed of a biocompatible material, and the device is sized and shaped to fit within a vascular cavity or vesicle, such as for treatment of an aneurysm or fistula. The vasoocclusive member can be first helically wound or braided in a generally linear fashion, and is then wound around an appropriately shaped mandrel or form, and heat treated to retain the shape after removal from the heating form. Radiopacity can be provided in the vasoocclusive members by weaving in synthetic or natural fibers filled with powdered radiopaque material, such as powdered tantalum, powdered tungsten, powdered bismuth oxide orpowd.ered barium sulfate, which can potentially be released during vascular surgery.
The delivery of such vasoocclusive devices can be accomplished by a variety of means, including via a catheter in which the device is pushed through the catheter by a pusher to deploy the device. The vasoocclusive devices, which can have a primary shape of a coil of wire that is then formed into a more complex secondary shape, can be produced in such a way that they will pass through the lumen of a catheter in a linear shape and take on a complex shape as originally formed after being deployed into the area of interest, such as an aneurysm. A variety of detachment mechanisms to release the device from a pusher have been developed and are known in the art.
For treatment of areas ofthe small diameter vasculature such as a small artery or vein in the brain, for example, and for treatment of aneurysms and the Iike, micro-coils formed of very small diameter wire are used in order to restrict, reinforce, or to occlude such small diameter areas ofthe vasculature. A variety ofmaterials have been suggested for use in such micro-coils, including nickel-titanium alloys, copper, stainless steel, platinum, tungsten, various plastics or the like, each of which offers certain benefits in various applications. Nickel-titanium alloys are particularly advantageous for the fabrication of such micro coils, in that they can have super-elastic or shape memory properties, and thus can be manufactured to easily fit into a linear portion of a catheter, but attain their originally formed, more complex shape when deployed.
One conventional vasoocclusive coil is known, for example, that has a three dimensional in-filling coil configuration, formed by winding a wire into a helix, and then winding the helix into a secondary form which forms a generally spherical shape, by winding the primary coil about poles placed on winding mandrel.
The secondary wound coil is then annealed on the winding mandrel, and the coil is then removed from the winding mandrel and loaded into a carrier for introduction into a delivery catheter. Another similar type of vasoocclusive device is known that can be formed from one or more strands, and can be wound to form a generally spherical or ovoid shape when released and relaxed at the site to be treated. Another implantable vasoocclusive device having multiple secondary layers of primary windings has a final shape that is a generally spherical coil formed of linear or helical primary coils that are wound into a secondary form having three layers. The inner 5 winding is wound and then the second layer formed by winding in the opposite direction of the first layer. The final configuration is a chunky or stepped shape approximately a sphere, ovoid, or egg. Yet another conventional implant for vessel occlusion is made from helical elements of metal or synthetic material by twisting or coiling the elements and forming them into a secondary shape such as a rosette or double rosette for implantation using a catheter, and another vasoocclusive device is known that has a final conical shape. However, due to the tendency of such three dimensional shaped coils to transform into their expanded, final forms when introduced into a catheter in the body, they are inherently more difficult than a helical coil or a straight wire or micro-cable to push through such a catheter for delivery to a site in the vasculature to be treated, due to friction between the coil and the catheter through which it is delivered to the site to be treated, which can even result in misalignment of the coil within the catheter during delivery.
There thus remains a need for a vasoocclusive device that has a three dimensional final form that can be used to fill an anatomical cavity at a site in the vasculature to be treated, reduces friction between the coil and the catheter through which it is delivered to the site to be treated, and ultimately helps to prevent coil misalignment. The present invention meets these and other needs.
BACKGROUND OF THE INVENTION
Field of the Invention:
This invention relates generally to vasoocclusive devices, and more particularly concerns a vasoocclusive device that has a first elongated, reduced friction configuration in which the vasoocclusive device may be deployed through a catheter or cannula to an anatomical cavity at a site in the vasculature to be treated, and that has a three dimensional second configuration assumed by the vasoocclusive device at the site to be treated for filling the anatomical cavity.
Description of Related Art:
The art and science of interventional therapy and surgery has continually progressed towards treatment of internal defects and diseases by use of ever smaller incisions or access through the vasculature or body openings in order to reduce the trauma to tissue surrounding the treatment site. One important aspect of such treatments involves the use of catheters to place therapeutic devices at a treatment site by access through the vasculature. Examples of such procedures include transluminal angioplasty, placement of stents to reinforce the walls of a blood 148121.1 vessel or the like and the use of vasoocclusive devices to treat defects in the vasculature. There is a constant drive by those practicing in the art to develop new and more capable systems for such applications. When coupled with developments in biological treatment capabilities, there is an expanding need for technologies that enhance the performance of interventional therapeutic devices and systems.
One specific field of interventional therapy that has been able to advantageously use recent developments in technology is the treatment of neurovascular defects. More specifically, as smaller and more capable structures and materials have been developed, treatment of vascular defects in the human brain which were previously untreatable or represented unacceptable risks via conventional surgery have become amenable to treatment. One type of non-surgical therapy that has become advantageous for the treatment of defects in the neurovasculature has been the placement by way of a catheter of vasoocclusive devices in a damaged portion of a vein or artery.
Vasoocclusion devices are therapeutic devices that are placed within the vasculature of the human body, typically via a catheter, either to block the flow of blood through a vessel making up that portion of the vasculature through the formation of an embolus or to form such an embolus within an aneurysm stemming from the vessel. The vasoocclusive devices can take a variety of configurations, and are generally formed of one or more elements that are larger in the deployed configuration than when they are within the delivery catheter prior to placement. One widely used vasoocclusive device is a helical wire coil having a deployed configuration which mav be dimensioned to engage the walls of the vessels. One anatomically shaped vasoocclusive device that forms itself into a shape of an anatomical cavity such as an aneurysm and is made of a pre-fortned strand of flexible material that can be anickel-titanium alloy is kno,,Arn from U.S. Patent No.
5,645,558.
That vasoocclusive device comprises one or more vasoocciusive members wound to form a generally spherical or ovoid shape in a relaxed state. The vasoocclusive members can be a helically wound coil or a co-woven braid formed of a biocompatible material, and the device is sized and shaped to fit within a vascular cavity or vesicle, such as for treatment of an aneurysm or fistula. The vasoocclusive member can be first helically wound or braided in a generally linear fashion, and is then wound around an appropriately shaped mandrel or form, and heat treated to retain the shape after removal from the heating form. Radiopacity can be provided in the vasoocclusive members by weaving in synthetic or natural fibers filled with powdered radiopaque material, such as powdered tantalum, powdered tungsten, powdered bismuth oxide orpowd.ered barium sulfate, which can potentially be released during vascular surgery.
The delivery of such vasoocclusive devices can be accomplished by a variety of means, including via a catheter in which the device is pushed through the catheter by a pusher to deploy the device. The vasoocclusive devices, which can have a primary shape of a coil of wire that is then formed into a more complex secondary shape, can be produced in such a way that they will pass through the lumen of a catheter in a linear shape and take on a complex shape as originally formed after being deployed into the area of interest, such as an aneurysm. A variety of detachment mechanisms to release the device from a pusher have been developed and are known in the art.
For treatment of areas ofthe small diameter vasculature such as a small artery or vein in the brain, for example, and for treatment of aneurysms and the Iike, micro-coils formed of very small diameter wire are used in order to restrict, reinforce, or to occlude such small diameter areas ofthe vasculature. A variety ofmaterials have been suggested for use in such micro-coils, including nickel-titanium alloys, copper, stainless steel, platinum, tungsten, various plastics or the like, each of which offers certain benefits in various applications. Nickel-titanium alloys are particularly advantageous for the fabrication of such micro coils, in that they can have super-elastic or shape memory properties, and thus can be manufactured to easily fit into a linear portion of a catheter, but attain their originally formed, more complex shape when deployed.
One conventional vasoocclusive coil is known, for example, that has a three dimensional in-filling coil configuration, formed by winding a wire into a helix, and then winding the helix into a secondary form which forms a generally spherical shape, by winding the primary coil about poles placed on winding mandrel.
The secondary wound coil is then annealed on the winding mandrel, and the coil is then removed from the winding mandrel and loaded into a carrier for introduction into a delivery catheter. Another similar type of vasoocclusive device is known that can be formed from one or more strands, and can be wound to form a generally spherical or ovoid shape when released and relaxed at the site to be treated. Another implantable vasoocclusive device having multiple secondary layers of primary windings has a final shape that is a generally spherical coil formed of linear or helical primary coils that are wound into a secondary form having three layers. The inner 5 winding is wound and then the second layer formed by winding in the opposite direction of the first layer. The final configuration is a chunky or stepped shape approximately a sphere, ovoid, or egg. Yet another conventional implant for vessel occlusion is made from helical elements of metal or synthetic material by twisting or coiling the elements and forming them into a secondary shape such as a rosette or double rosette for implantation using a catheter, and another vasoocclusive device is known that has a final conical shape. However, due to the tendency of such three dimensional shaped coils to transform into their expanded, final forms when introduced into a catheter in the body, they are inherently more difficult than a helical coil or a straight wire or micro-cable to push through such a catheter for delivery to a site in the vasculature to be treated, due to friction between the coil and the catheter through which it is delivered to the site to be treated, which can even result in misalignment of the coil within the catheter during delivery.
There thus remains a need for a vasoocclusive device that has a three dimensional final form that can be used to fill an anatomical cavity at a site in the vasculature to be treated, reduces friction between the coil and the catheter through which it is delivered to the site to be treated, and ultimately helps to prevent coil misalignment. The present invention meets these and other needs.
SUMMARY OF THE INVENTION
Briefly, and in general terms, the present invention provides for an improved vasoocclusive coil, and a method of making the coil, that has a distal portion that is three dimensionally shaped, and a proximal portion that is linear or helically shaped, in order to combine the best qualities of a three dimensional coil and a linear or helical coil. The distal three dimensional portion will form a basket for filling the anatomical cavity at the site in the vasculature to be treated, while the proximal portion will fill and reinforce the basket. This combination will reduce friction within a catheter or cannula being used to deliver the vasoocclusive coil to the site in the vasculature to be treated, and ultimately helps prevent coil realignment or misalignment. The ultimate coil volume that otherwise might be limited due to frictional constraints of three dimensional coils will not be compromised with the device of the present invention.
The present invention accordingly provides for a vasoocclusive device that is adapted to be inserted into a portion of a vasculature for occluding the portion of the vasculature for use in interventional therapy and vascular surgery. The vasoocclusive device comprises at least one strand of a flexible material fonmed to have an a first inoperable, substantially linear configuration for insertion into and through a catheter or cannula to a desired portion of the vasculature to be treated, and a second operable, three dimensional configuration for occluding the desired portion of the vasculature to be treated. The vasoocclusive device advantageously has a distal portion having a second operable, three dimensional shape for filling the anatomical cavity at the site in the vasculature to be treated, and a proximal portion having a second operable, substantially linear shape for filling and reinforcing the distal, three dimensional shaped portion when it is implanted at the site in the vasculature to be treated.
The present invention also provides for a method of making the vasoocclusive device. The method generally comprises the steps of winding at least one strand of a flexible shape memory material about a mandrel formed of a refractory material in a three dimensional configuration of the vasoocclusive coil to form a distal portion of the vasoocclusive coil; heating the at least one strand of a flexible shape memory material wound about the mandrel for a sufficient period of time to impart the form to the shape memory material included in the device to form an operable, three dimensional configuration ofthe vasoocclusive coil; removing the vasoocclusive coil from the mandrel; and cold working the vasoocclusive coil into a desired elongated configuration for placement into a catheter or cannula for use. In one presently preferred embodiment, the mandrel about which the at least one flexible strand forming the vasoocclusive coil is wound has a substantially spherical body portion having a plurality of circumferential grooves to form a three dimensional configuration of a distal portion of the vasoocclusive coil. In another presently preferred embodiment, the mandrel about which the at least one flexible strand forming the vasoocclusive coil is wound has a substantially spherical body with a plurality of posts disposed on the body. In a preferred aspect, six posts are disposed on the body aligned with the three orthogonal x, y and z axes through the body of the mandrel, for aligning and shaping the distal portion of the vasoocclusive device as it is wound on the mandrel. One of the posts is preferably made longer than the other posts, to serve as a mandrel for helically winding the proximal portion of the vasoocclusive coil. In another preferred aspect of the method, the step of heating comprises heating the at least one strand of a flexible shape memory material wound about the mandrel at a temperature of about 1100 F for at least about 4 hours to impart the form to the shape memory material included in the device to form an operable, three dimensional configuration of the distal portion of the vasoocclusive coil.
Thus, in a broad aspect the invention provides a vasoocclusive device that is adapted to be inserted into a portion of a vasculature for occluding the portion of the vasculature for use in interventional therapy and vascular surgery, comprising: at least one multi-stranded micro-cable formed to have a first inoperable, substantially linear configuration for insertion into and through a catheter to a desired portion of the vasculature to be treated, and a second operable, three dimensional configuration for occluding the desired part of the vasculature to be treated; said vasoocclusive device further having a distal portion having a second operable, three dimensional shape for filling the anatomical cavity at the site in the vasculature to be treated, and a proximal portion having a second operable, substantially linear shape for filling and reinforcing the distal, three dimensional shaped portion when the vasoocclusive device is implanted at the site in the vasculature to be treated, each said multi-stranded micro-cable having a plurality of flexible strands of a resilient material comprising a central core, and at 8a least one radiopaque strand to provide a radiopaque marker of the deployed configuration of a device made of the cable during vascular surgery.
In another broad aspect the invention provides a vasoocclusive device that is adapted to be inserted into a portion of a vasculature for occluding the portion of the vasculature for use in interventional therapy and vascular surgery, comprising: at least one multi-stranded micro-cable formed to have a first inoperable, substantially linear configuration for insertion into and through a catheter to a desired portion of the vasculature to be treated, and a second operable, three dimensional configuration for occluding the desired part of the vasculature to be treated; said vasoocclusive device further having a distal portion having a second operable, three dimensional shape for filling the anatomical cavity at the site in the vasculature to be treated, and a proximal portion having a second operable, substantially linear shape for filling and reinforcing the distal, three dimensional shaped portion when the vasoocclusive device is implanted at the site in the vasculature to be treated, each said multi-stranded micro-cable having a plurality of flexible strands of a resilient material comprising a central core, and at least one radiopaque strand to provide a radiopaque marker of the deployed configuration of a device made of the cable during vascular surgery, and wherein said strands of the micro-cable are bundled by at least one outer cover comprising a sheath to constrain said strands about a longitudinal axis to produce a composite banded cable.
In another broad aspect the invention provides a method of making a vasoocclusive device that is adapted to be inserted into a portion of a vasculature for occluding the portion of the vasculature for use in interventional 8b therapy and vascular surgery, said vasoocclusive device being formed from at least one strand of a flexible shape memory material formed to have a first inoperable, substantially linear configuration for insertion into and through a catheter to a desired portion of the vasculature to be treated, and a second operable, three dimensional configuration for occluding the desired portion of the vasculature to be treated, said vasoocclusive device having a distal portion having a second operable, three dimensionally shape, and a proximal portion having a second operable, substantially linear shape, the method comprising the steps of: winding at least one strand of a flexible shape memory material about a mandrel in a three dimensional configuration of the vasoocclusive coil to form a distal portion of the vasoocclusive coil; heating said at least one strand of a flexible shape memory material wound about the mandrel for a sufficient period of time to impart the form to the shape memory material included in the device to form an operable, three dimensional configuration of the vasoocclusive coil; removing the vasoocclusive coil from the mandrel; and cold working the vasoocclusive coil into a desired elongated configuration for placement into a catheter or cannula for use.
These and other aspects and advantages of the invention will become apparent from the following detailed description and the accompanying drawings, which illustrate by way of example the features of the invention.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 is a cross section of a vascular member with an aneurysm illustrating the approach of a vasoocclusive coil towards the aneurysm.
8c Figure 2 is a side elevational view showing a first embodiment of a second operable, three dimensional configuration of the vasoocclusive coil of the invention.
Figure 3 is a side elevational view showing a second embodiment of a second operable, three dimensional configuration of the vasoocclusive coil of the invention.
Figure 4 is a perspective view of a radiopaque microstrand cable used in forming the vasoocclusive coil according to the invention.
Figure 5 is a cross-section at 5-5 of Figure 4.
Figure 6 is an alternate preferred embodiment of the invention including a plurality of radiopaque strands within the cable.
Figure 7 is an alternate preferred embodiment of the present invention wherein strands of the cable are arranged within an exterior binding consisting of multiple straps about the cable.
Figure 8 is a perspective view of the embodiment of Figure 7.
Figure 9 is an alternative embodiment to the embodiment of Figure 8 wherein the external binding of the cable represents a sheath wound about the cable.
Figures l 0a and l Ob areperspectives of alternative embodiments of the embodiment of Figure 9.
Figure 11 is a cross-section of an alternative embodiment in which a plurality of multi-strand cables are included within an external sheath surrounding the cable.
Figure 12 is a perspective view of the embodiment of Figure 11.
Figure 13A is a top plan view of a first embodiment of a mandrel used for making the vasoocclusive coil according to the method of the invention.
Figure 13B is a perspective view of the mandrel of Figure 13A.
Figure 14 is a plan view of a variant of the first embodiment of Figures 13A and 13B.
Figure 15A is a top plan view of a second preferred embodiment of a mandrel used for making the vasoocclusive coil according to the method of the 5 invention.
Figure 15B is a front plan view of the mandrel of Figure 15A.
Figure 15C is a bottom plan view of the mandrel of Figure 15A.
Figure 15D is a left side plan view of the mandrel of Figure 15A.
Figure 15E is a right side plan view of the mandrel of Figure 15A.
Briefly, and in general terms, the present invention provides for an improved vasoocclusive coil, and a method of making the coil, that has a distal portion that is three dimensionally shaped, and a proximal portion that is linear or helically shaped, in order to combine the best qualities of a three dimensional coil and a linear or helical coil. The distal three dimensional portion will form a basket for filling the anatomical cavity at the site in the vasculature to be treated, while the proximal portion will fill and reinforce the basket. This combination will reduce friction within a catheter or cannula being used to deliver the vasoocclusive coil to the site in the vasculature to be treated, and ultimately helps prevent coil realignment or misalignment. The ultimate coil volume that otherwise might be limited due to frictional constraints of three dimensional coils will not be compromised with the device of the present invention.
The present invention accordingly provides for a vasoocclusive device that is adapted to be inserted into a portion of a vasculature for occluding the portion of the vasculature for use in interventional therapy and vascular surgery. The vasoocclusive device comprises at least one strand of a flexible material fonmed to have an a first inoperable, substantially linear configuration for insertion into and through a catheter or cannula to a desired portion of the vasculature to be treated, and a second operable, three dimensional configuration for occluding the desired portion of the vasculature to be treated. The vasoocclusive device advantageously has a distal portion having a second operable, three dimensional shape for filling the anatomical cavity at the site in the vasculature to be treated, and a proximal portion having a second operable, substantially linear shape for filling and reinforcing the distal, three dimensional shaped portion when it is implanted at the site in the vasculature to be treated.
The present invention also provides for a method of making the vasoocclusive device. The method generally comprises the steps of winding at least one strand of a flexible shape memory material about a mandrel formed of a refractory material in a three dimensional configuration of the vasoocclusive coil to form a distal portion of the vasoocclusive coil; heating the at least one strand of a flexible shape memory material wound about the mandrel for a sufficient period of time to impart the form to the shape memory material included in the device to form an operable, three dimensional configuration ofthe vasoocclusive coil; removing the vasoocclusive coil from the mandrel; and cold working the vasoocclusive coil into a desired elongated configuration for placement into a catheter or cannula for use. In one presently preferred embodiment, the mandrel about which the at least one flexible strand forming the vasoocclusive coil is wound has a substantially spherical body portion having a plurality of circumferential grooves to form a three dimensional configuration of a distal portion of the vasoocclusive coil. In another presently preferred embodiment, the mandrel about which the at least one flexible strand forming the vasoocclusive coil is wound has a substantially spherical body with a plurality of posts disposed on the body. In a preferred aspect, six posts are disposed on the body aligned with the three orthogonal x, y and z axes through the body of the mandrel, for aligning and shaping the distal portion of the vasoocclusive device as it is wound on the mandrel. One of the posts is preferably made longer than the other posts, to serve as a mandrel for helically winding the proximal portion of the vasoocclusive coil. In another preferred aspect of the method, the step of heating comprises heating the at least one strand of a flexible shape memory material wound about the mandrel at a temperature of about 1100 F for at least about 4 hours to impart the form to the shape memory material included in the device to form an operable, three dimensional configuration of the distal portion of the vasoocclusive coil.
Thus, in a broad aspect the invention provides a vasoocclusive device that is adapted to be inserted into a portion of a vasculature for occluding the portion of the vasculature for use in interventional therapy and vascular surgery, comprising: at least one multi-stranded micro-cable formed to have a first inoperable, substantially linear configuration for insertion into and through a catheter to a desired portion of the vasculature to be treated, and a second operable, three dimensional configuration for occluding the desired part of the vasculature to be treated; said vasoocclusive device further having a distal portion having a second operable, three dimensional shape for filling the anatomical cavity at the site in the vasculature to be treated, and a proximal portion having a second operable, substantially linear shape for filling and reinforcing the distal, three dimensional shaped portion when the vasoocclusive device is implanted at the site in the vasculature to be treated, each said multi-stranded micro-cable having a plurality of flexible strands of a resilient material comprising a central core, and at 8a least one radiopaque strand to provide a radiopaque marker of the deployed configuration of a device made of the cable during vascular surgery.
In another broad aspect the invention provides a vasoocclusive device that is adapted to be inserted into a portion of a vasculature for occluding the portion of the vasculature for use in interventional therapy and vascular surgery, comprising: at least one multi-stranded micro-cable formed to have a first inoperable, substantially linear configuration for insertion into and through a catheter to a desired portion of the vasculature to be treated, and a second operable, three dimensional configuration for occluding the desired part of the vasculature to be treated; said vasoocclusive device further having a distal portion having a second operable, three dimensional shape for filling the anatomical cavity at the site in the vasculature to be treated, and a proximal portion having a second operable, substantially linear shape for filling and reinforcing the distal, three dimensional shaped portion when the vasoocclusive device is implanted at the site in the vasculature to be treated, each said multi-stranded micro-cable having a plurality of flexible strands of a resilient material comprising a central core, and at least one radiopaque strand to provide a radiopaque marker of the deployed configuration of a device made of the cable during vascular surgery, and wherein said strands of the micro-cable are bundled by at least one outer cover comprising a sheath to constrain said strands about a longitudinal axis to produce a composite banded cable.
In another broad aspect the invention provides a method of making a vasoocclusive device that is adapted to be inserted into a portion of a vasculature for occluding the portion of the vasculature for use in interventional 8b therapy and vascular surgery, said vasoocclusive device being formed from at least one strand of a flexible shape memory material formed to have a first inoperable, substantially linear configuration for insertion into and through a catheter to a desired portion of the vasculature to be treated, and a second operable, three dimensional configuration for occluding the desired portion of the vasculature to be treated, said vasoocclusive device having a distal portion having a second operable, three dimensionally shape, and a proximal portion having a second operable, substantially linear shape, the method comprising the steps of: winding at least one strand of a flexible shape memory material about a mandrel in a three dimensional configuration of the vasoocclusive coil to form a distal portion of the vasoocclusive coil; heating said at least one strand of a flexible shape memory material wound about the mandrel for a sufficient period of time to impart the form to the shape memory material included in the device to form an operable, three dimensional configuration of the vasoocclusive coil; removing the vasoocclusive coil from the mandrel; and cold working the vasoocclusive coil into a desired elongated configuration for placement into a catheter or cannula for use.
These and other aspects and advantages of the invention will become apparent from the following detailed description and the accompanying drawings, which illustrate by way of example the features of the invention.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 is a cross section of a vascular member with an aneurysm illustrating the approach of a vasoocclusive coil towards the aneurysm.
8c Figure 2 is a side elevational view showing a first embodiment of a second operable, three dimensional configuration of the vasoocclusive coil of the invention.
Figure 3 is a side elevational view showing a second embodiment of a second operable, three dimensional configuration of the vasoocclusive coil of the invention.
Figure 4 is a perspective view of a radiopaque microstrand cable used in forming the vasoocclusive coil according to the invention.
Figure 5 is a cross-section at 5-5 of Figure 4.
Figure 6 is an alternate preferred embodiment of the invention including a plurality of radiopaque strands within the cable.
Figure 7 is an alternate preferred embodiment of the present invention wherein strands of the cable are arranged within an exterior binding consisting of multiple straps about the cable.
Figure 8 is a perspective view of the embodiment of Figure 7.
Figure 9 is an alternative embodiment to the embodiment of Figure 8 wherein the external binding of the cable represents a sheath wound about the cable.
Figures l 0a and l Ob areperspectives of alternative embodiments of the embodiment of Figure 9.
Figure 11 is a cross-section of an alternative embodiment in which a plurality of multi-strand cables are included within an external sheath surrounding the cable.
Figure 12 is a perspective view of the embodiment of Figure 11.
Figure 13A is a top plan view of a first embodiment of a mandrel used for making the vasoocclusive coil according to the method of the invention.
Figure 13B is a perspective view of the mandrel of Figure 13A.
Figure 14 is a plan view of a variant of the first embodiment of Figures 13A and 13B.
Figure 15A is a top plan view of a second preferred embodiment of a mandrel used for making the vasoocclusive coil according to the method of the 5 invention.
Figure 15B is a front plan view of the mandrel of Figure 15A.
Figure 15C is a bottom plan view of the mandrel of Figure 15A.
Figure 15D is a left side plan view of the mandrel of Figure 15A.
Figure 15E is a right side plan view of the mandrel of Figure 15A.
10 Figure 15F is a rear plan view of the mandrel of Figure 15A.
Figure 16A is a front plan view of a third preferred embodiment of a mandrel used for making the vasoocclusive coil according to the method of the invention.
Figure 16B is a bottom plan view of the mandrel of Figure 16A.
Figure 16C is a left side plan view of the mandrel of Figure 16A.
Figure 16D is a right side plan view of the mandrel of Figure 16A.
Figure 16E is a rear plan view of the mandrel of Figure 16A.
Figure 17A is a top plan view of a fourth preferred embodiment of a mandrel used for making the vasoocclusive coil according to the method of the invention.
Figure 17B is a front plan view of the mandrel of Figure 17A.
Figure 17C is a bottom plan view of the mandrel of Figure 17A.
Figure 16A is a front plan view of a third preferred embodiment of a mandrel used for making the vasoocclusive coil according to the method of the invention.
Figure 16B is a bottom plan view of the mandrel of Figure 16A.
Figure 16C is a left side plan view of the mandrel of Figure 16A.
Figure 16D is a right side plan view of the mandrel of Figure 16A.
Figure 16E is a rear plan view of the mandrel of Figure 16A.
Figure 17A is a top plan view of a fourth preferred embodiment of a mandrel used for making the vasoocclusive coil according to the method of the invention.
Figure 17B is a front plan view of the mandrel of Figure 17A.
Figure 17C is a bottom plan view of the mandrel of Figure 17A.
Figure 17D is a left side plan view of the mandrel of Figure 17A.
Figure 17E is a right side plan view of the mandrel of Figure 17A.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
While conventional three dimensional and spherical vasoocclusive coils have been developed, such three dimensional shaped coils tend to transform into their expanded, final forms when introduced into a catheter in the body, making them inherently more difficult than a simple helical coil or straight wire to push through a catheter or cannula for delivery to a site in the vasculature to be treated, due to friction between the coil and the catheter through which it is delivered to the site to be treated, and that can even result in misalignment of the coil within the catheter during delivery.
As is illustrated in the drawings, the invention is accordingly embodied in a vasoocclusive device that is adapted to be inserted into a portion of a vasculature for occluding the portion of the vasculature for use in interventional therapy and vascular surgery. The vasoocclusive coil 1 is formed from at least one strand of a flexible material formed to have a first inoperable, substantially linear configuration, as illustrated in Figure 1, for insertion through a micro-catheter 2 into a desired portion of the vasculature to be treated, such as an aneurysm, or other anatomical malforrnation of the vasculature to be treated, and a second operable, three dimensional configuration, as illustrated in Figures 2 and 3, for occluding the desired portion of the vasculature to be treated.
Figure 1 illustrates a helically wound vasoocclusive coil 1 which is formed to fit within the micro-catheter for insertion into an area upon which a therapeutic procedure is to be performed. Figure I further shows a catheter pusher member 3 for delivering a vasoocclusive coil I for insertion into an aneurysm projecting laterally from a blood vessel 5. The end of the micro-catheter 2 is typically introduced into the opening of the aneurism by use of a guide wire (note shown), and the coil and pusher member are introduced into the micro-catheter to insert the vasoocclusive coil into the aneurysm. In a presently preferred embodiment, catheter pusher member to which the vasoocclusive coil is mounted is an optical fiber pusher which is attached to the coil by a collar 6 of shape memory material as described in U.S. Patent Nos. 6,159,165 and 6,168,615. The vasoocclusive coil is typically introduced into the aneurysm and is then pushed from the micro-catheter until the vasoocclusive coil fills the cavity.
In one presently preferred embodiment, the shape memory collar 6 is heated to a temperature which allows it to be shrunk onto the vasoocclusive coil. The collar can be attached to optical fiber pusher by an adhesive which retains high strength at temperatures beyond the shape memory material transition point.
After insertion, and when an operator is satisfied that the device is properly deployed, light energy from a source of coherent light is introduced into the proximal end of the optical fiber (not shown) and propagated in the distal end 7 of the fiber to cause the shape memory material collar to return to its previous shape and release the vasoocclusive coil. Those skilled in the art will recognize that the invention can also be used with a variety of other placement catheter systems, and it is not intended that the invention be limited to the placement concepts illustrated by way of example.
Referring to Figures 2 and 3, the vasoocclusive device preferably has a distal portion 8 having a second operable, three dimensional shape for filling the anatomical cavity at the site in the vasculature to be treated, and a proximal portion having a second operable, substantially linear shape for filling and reinforcing the distal, three dimensional shaped portion when the vasoocclusive device is implanted at the site in the vasculature to be treated. The distal portion preferably has a second operable, three dimensional shape that is substantially spherical. As is illustrated in Figure 2, in one presently preferred embodiment, the proximal portion 9 is substantially linear, and as is illustrated in Figure 3, in another presently preferred embodiment, the proximal portion 9' is substantially helical.
In a presently preferred aspect ofthe invention, the vasoocclusive coils are fonmed from a multi-stranded micro-cable, although the vasoocclusive coils can also be made from a single strand of a flexible material formed to have an a first inoperable, substantially linear configuration for insertion into and through a catheter or cannula to a desired portion of the vasculature to be treated, and a second operable, three dimensional configuration for occluding the desired portion of the vasculature to be treated. As is illustrated in Figure 4, the vasoocclusive coils are preferably formed from a multi-stranded micro-cable 10 that is typically approximately from .0021 to .0045 inches in diameter, and comprises a plurality of flexible strands 12 of nickel-titanium alloy, with at least one centrally, axially disposed radiopaque wire 14 which is approximately from .0007 to .0015 inches in diameter. While the above stated diameters represent those presently known to be compatible with the invention, larger or smaller diameters may be useful for particular applications. The central radiopaque wire 14 can be formed of platinum or gold, for example, or other similar suitable radiopaque metals, in order to provide a radiopaque marker of the deployed configuration of a device made of the cable during vascular surgery.
There are numerous benefits to the novel construction of the invention for use in interventional devices and the like. By using the stranded or micro-cable construction of the invention, a vasoocclusive device made from the micro-cable becomes virtually kink resistant compared to the single strand wires now commonly used in micro-coils. The multi-strand cable construction of the invention allows the micro-wires of the cable to slip across each other and reinforce each other rather than break or take a set. Also, by incorporating a stranded radiopaque material such as platinum, tungsten or gold into the cable construction, the device is radiopaque in sizes much smaller than with other constructions.
Figure 5 is a cross-section of the micro-cable of Figure 4 at 5-5 illustrating one presently preferred arrangement of the strands within the cable. In this embodiment, the exterior strands 12 are formed of a resilient material chosen to provide the characteristics desired for a specific application in interventional therapies.
In a presently preferred embodiment, this material is a nickel titanium super-elastic alloy which is heat treated such that the alloy is highly flexible at a temperature appropriate for introduction into the body via a catheter or cannula. By choosing such a material for micro-coils and the like, the devices formed from the micro-cable can be relatively easily placed into the appropriate body cavity and after placement, the 5 device will take on a shape designed to optimize the therapeutic purposes desired for the device. As illustrated in Figure 5, such a cable can have a central core 14 of a radiopaque material such as gold or platinum, thus dramatically enhancing the radiopacity of the cable. Even a solid super-elastic wire of the same diameter as the cable would have substantially less radiopacity than the cable of the invention with 10 the central gold or platinum wire and the construction of the invention provides numerous other highly desirable characteristics. Among these characteristics is the relative flexibility and resistance to kinking of the cable compared to an equivalent single wire and substantially greater accommodation of the cable to bending, etc., with resultant lessening of trauma to the surrounding tissue and ease of placement in a 15 small body cavity.
While one presently preferred implementation ofthe micro-cable ofthe invention has been illustrated, those skilled in the art will appreciate that other variations of the invention may have advantages for certain purposes. Figure 6 is an example of one such construction 40 in which radiopacity is more desirable than in other fonms and for that reason a number of radiopaque strands 42, in this illustration four in number, are formed into the cable along with three resilient material strands 44. It will also be appreciated that a larger or smaller number of strands may be incorporated into a given cable and the cables may be formed of multiple cables in order to provide desired bending and strength characteristics. It will also be appreciated by those skilled in the art that the invention is adaptable to the use of a variety of materials which by themselves would not have been easily adaptable to micro devices for interventional therapies. For instance, materials such as copper are useful for intrauterine devices and the like, but copper wire, even when heavily alloyed, has certain limitations for use in such devices. By use of the present invention, composite cables incorporating one or more strands of a desired material can be configured with other strands providing strength, flexibility, shape memory, super-elasticity, radiopacity or the like for previously unavailable characteristics in micro devices.
Figure 7 illustrates a cross-section of an additional presently preferred embodiment of the invention in which the strands 12, 14 of the micro-cable 10 are bundled and banded at intervals by bands 50 to produce a composite banded cable 52 in order to provide increased flexibility without unraveling or dislocation of the strands in the cable. Figure 8 is a perspective view of the banded cable 50 of this embodiment. While the illustrated configuration shows the strands being laid parallel within the cable, it is also possible in this construction to include both twisted cables as the primary cables 10 within the outer bands 50 to form the composite cable 52.
This configuration can use one or more longitudinal strands 14 which are radiopaque, thus providing a continuous indication of radiopacity within the cable. As a further alternative embodiment, it is possible for the longitudinal cable 52 to be formed of a single inner cable 10 with bands 50.
Figure 9 illustrates a further embodiment of the invention in which longitudinal strands of cables are contained within a wound cover 56 for the purposes of providing a composite guide wire or the like 58 having improved torqueability.
Such a construction has particular advantages for guidewire designs having improved radiopacity in very small diameters. It will be appreciated that in this configuration, as well as the other longitudinally anranged multi-stranded cables, the number of strands and the degree to which they extend along the cable within the sheath is a variable which can be used to provide increased stiffness, pushability and torqueability in some sections with greater flexibility in others. Additionally, composite cables according to the invention can incorporate additional elements normally not available in solid guide wires, such as optical, thermal or ultrasound imaging elements, therapeutic agent delivery catheters, and can take advantage of materials which are not readily adaptable to prior art catheter or guide wire designs incorporating a primary wire structured element. Figures l0a and lOb illustrate a further variable available because of the invention; the exterior wrapped cover 56 can be wound at greater or lesser intervals 60 along the outside to provide variations in the torqueability and stiffness of the composite cable. Also, the thickness and width of the wrapping cover 56, as well as its material composition along the composite guide wire 58, can offer further capabilities for customizing the design for various applications.
These advantages can be combined with the benefits of shape memory or super-elastic alloys to create guidewires and other devices with heretofore unavailable capabilities.
Figure 17E is a right side plan view of the mandrel of Figure 17A.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
While conventional three dimensional and spherical vasoocclusive coils have been developed, such three dimensional shaped coils tend to transform into their expanded, final forms when introduced into a catheter in the body, making them inherently more difficult than a simple helical coil or straight wire to push through a catheter or cannula for delivery to a site in the vasculature to be treated, due to friction between the coil and the catheter through which it is delivered to the site to be treated, and that can even result in misalignment of the coil within the catheter during delivery.
As is illustrated in the drawings, the invention is accordingly embodied in a vasoocclusive device that is adapted to be inserted into a portion of a vasculature for occluding the portion of the vasculature for use in interventional therapy and vascular surgery. The vasoocclusive coil 1 is formed from at least one strand of a flexible material formed to have a first inoperable, substantially linear configuration, as illustrated in Figure 1, for insertion through a micro-catheter 2 into a desired portion of the vasculature to be treated, such as an aneurysm, or other anatomical malforrnation of the vasculature to be treated, and a second operable, three dimensional configuration, as illustrated in Figures 2 and 3, for occluding the desired portion of the vasculature to be treated.
Figure 1 illustrates a helically wound vasoocclusive coil 1 which is formed to fit within the micro-catheter for insertion into an area upon which a therapeutic procedure is to be performed. Figure I further shows a catheter pusher member 3 for delivering a vasoocclusive coil I for insertion into an aneurysm projecting laterally from a blood vessel 5. The end of the micro-catheter 2 is typically introduced into the opening of the aneurism by use of a guide wire (note shown), and the coil and pusher member are introduced into the micro-catheter to insert the vasoocclusive coil into the aneurysm. In a presently preferred embodiment, catheter pusher member to which the vasoocclusive coil is mounted is an optical fiber pusher which is attached to the coil by a collar 6 of shape memory material as described in U.S. Patent Nos. 6,159,165 and 6,168,615. The vasoocclusive coil is typically introduced into the aneurysm and is then pushed from the micro-catheter until the vasoocclusive coil fills the cavity.
In one presently preferred embodiment, the shape memory collar 6 is heated to a temperature which allows it to be shrunk onto the vasoocclusive coil. The collar can be attached to optical fiber pusher by an adhesive which retains high strength at temperatures beyond the shape memory material transition point.
After insertion, and when an operator is satisfied that the device is properly deployed, light energy from a source of coherent light is introduced into the proximal end of the optical fiber (not shown) and propagated in the distal end 7 of the fiber to cause the shape memory material collar to return to its previous shape and release the vasoocclusive coil. Those skilled in the art will recognize that the invention can also be used with a variety of other placement catheter systems, and it is not intended that the invention be limited to the placement concepts illustrated by way of example.
Referring to Figures 2 and 3, the vasoocclusive device preferably has a distal portion 8 having a second operable, three dimensional shape for filling the anatomical cavity at the site in the vasculature to be treated, and a proximal portion having a second operable, substantially linear shape for filling and reinforcing the distal, three dimensional shaped portion when the vasoocclusive device is implanted at the site in the vasculature to be treated. The distal portion preferably has a second operable, three dimensional shape that is substantially spherical. As is illustrated in Figure 2, in one presently preferred embodiment, the proximal portion 9 is substantially linear, and as is illustrated in Figure 3, in another presently preferred embodiment, the proximal portion 9' is substantially helical.
In a presently preferred aspect ofthe invention, the vasoocclusive coils are fonmed from a multi-stranded micro-cable, although the vasoocclusive coils can also be made from a single strand of a flexible material formed to have an a first inoperable, substantially linear configuration for insertion into and through a catheter or cannula to a desired portion of the vasculature to be treated, and a second operable, three dimensional configuration for occluding the desired portion of the vasculature to be treated. As is illustrated in Figure 4, the vasoocclusive coils are preferably formed from a multi-stranded micro-cable 10 that is typically approximately from .0021 to .0045 inches in diameter, and comprises a plurality of flexible strands 12 of nickel-titanium alloy, with at least one centrally, axially disposed radiopaque wire 14 which is approximately from .0007 to .0015 inches in diameter. While the above stated diameters represent those presently known to be compatible with the invention, larger or smaller diameters may be useful for particular applications. The central radiopaque wire 14 can be formed of platinum or gold, for example, or other similar suitable radiopaque metals, in order to provide a radiopaque marker of the deployed configuration of a device made of the cable during vascular surgery.
There are numerous benefits to the novel construction of the invention for use in interventional devices and the like. By using the stranded or micro-cable construction of the invention, a vasoocclusive device made from the micro-cable becomes virtually kink resistant compared to the single strand wires now commonly used in micro-coils. The multi-strand cable construction of the invention allows the micro-wires of the cable to slip across each other and reinforce each other rather than break or take a set. Also, by incorporating a stranded radiopaque material such as platinum, tungsten or gold into the cable construction, the device is radiopaque in sizes much smaller than with other constructions.
Figure 5 is a cross-section of the micro-cable of Figure 4 at 5-5 illustrating one presently preferred arrangement of the strands within the cable. In this embodiment, the exterior strands 12 are formed of a resilient material chosen to provide the characteristics desired for a specific application in interventional therapies.
In a presently preferred embodiment, this material is a nickel titanium super-elastic alloy which is heat treated such that the alloy is highly flexible at a temperature appropriate for introduction into the body via a catheter or cannula. By choosing such a material for micro-coils and the like, the devices formed from the micro-cable can be relatively easily placed into the appropriate body cavity and after placement, the 5 device will take on a shape designed to optimize the therapeutic purposes desired for the device. As illustrated in Figure 5, such a cable can have a central core 14 of a radiopaque material such as gold or platinum, thus dramatically enhancing the radiopacity of the cable. Even a solid super-elastic wire of the same diameter as the cable would have substantially less radiopacity than the cable of the invention with 10 the central gold or platinum wire and the construction of the invention provides numerous other highly desirable characteristics. Among these characteristics is the relative flexibility and resistance to kinking of the cable compared to an equivalent single wire and substantially greater accommodation of the cable to bending, etc., with resultant lessening of trauma to the surrounding tissue and ease of placement in a 15 small body cavity.
While one presently preferred implementation ofthe micro-cable ofthe invention has been illustrated, those skilled in the art will appreciate that other variations of the invention may have advantages for certain purposes. Figure 6 is an example of one such construction 40 in which radiopacity is more desirable than in other fonms and for that reason a number of radiopaque strands 42, in this illustration four in number, are formed into the cable along with three resilient material strands 44. It will also be appreciated that a larger or smaller number of strands may be incorporated into a given cable and the cables may be formed of multiple cables in order to provide desired bending and strength characteristics. It will also be appreciated by those skilled in the art that the invention is adaptable to the use of a variety of materials which by themselves would not have been easily adaptable to micro devices for interventional therapies. For instance, materials such as copper are useful for intrauterine devices and the like, but copper wire, even when heavily alloyed, has certain limitations for use in such devices. By use of the present invention, composite cables incorporating one or more strands of a desired material can be configured with other strands providing strength, flexibility, shape memory, super-elasticity, radiopacity or the like for previously unavailable characteristics in micro devices.
Figure 7 illustrates a cross-section of an additional presently preferred embodiment of the invention in which the strands 12, 14 of the micro-cable 10 are bundled and banded at intervals by bands 50 to produce a composite banded cable 52 in order to provide increased flexibility without unraveling or dislocation of the strands in the cable. Figure 8 is a perspective view of the banded cable 50 of this embodiment. While the illustrated configuration shows the strands being laid parallel within the cable, it is also possible in this construction to include both twisted cables as the primary cables 10 within the outer bands 50 to form the composite cable 52.
This configuration can use one or more longitudinal strands 14 which are radiopaque, thus providing a continuous indication of radiopacity within the cable. As a further alternative embodiment, it is possible for the longitudinal cable 52 to be formed of a single inner cable 10 with bands 50.
Figure 9 illustrates a further embodiment of the invention in which longitudinal strands of cables are contained within a wound cover 56 for the purposes of providing a composite guide wire or the like 58 having improved torqueability.
Such a construction has particular advantages for guidewire designs having improved radiopacity in very small diameters. It will be appreciated that in this configuration, as well as the other longitudinally anranged multi-stranded cables, the number of strands and the degree to which they extend along the cable within the sheath is a variable which can be used to provide increased stiffness, pushability and torqueability in some sections with greater flexibility in others. Additionally, composite cables according to the invention can incorporate additional elements normally not available in solid guide wires, such as optical, thermal or ultrasound imaging elements, therapeutic agent delivery catheters, and can take advantage of materials which are not readily adaptable to prior art catheter or guide wire designs incorporating a primary wire structured element. Figures l0a and lOb illustrate a further variable available because of the invention; the exterior wrapped cover 56 can be wound at greater or lesser intervals 60 along the outside to provide variations in the torqueability and stiffness of the composite cable. Also, the thickness and width of the wrapping cover 56, as well as its material composition along the composite guide wire 58, can offer further capabilities for customizing the design for various applications.
These advantages can be combined with the benefits of shape memory or super-elastic alloys to create guidewires and other devices with heretofore unavailable capabilities.
Figures 11 and 12 illustrate a cross-section of a micro-cable according to the invention which has at least one overall exterior sheath to contain the micro-cable. The micro-cable may be made of one or more multiple strand elements which may further include twisted or longitudinal strands within their construction. The sheath may also be used to control the torqueability characteristics of the cable and as discussed in U.S. Patent 6,168,570, the sheath may be multi-layered with different materials in order to provide a graduated bending and stiffness characteristic over the length of the cable.
It will be appreciated that a three dimensional occlusive device adapted to be inserted into a portion of a vasculature for occluding the portion of the vasculature for use in interventional therapy and vascular surgery, can be formed as described above, from at least one multi-stranded micro-cable having a plurality of flexible strands of a resilient material, with at least one radiopaque strand to provide a radiopaque marker for the device during vascular surgery. The occlusive device is configured to have a first inoperable, substantially linear, elongated configuration for insertion into and through a catheter or cannula to a desired portion of the vasculature to be treated, and a second operable, three dimensional configuration for occluding the desired portion of the vasculature to be treated.
In the method of making the vasoocclusive coils of the invention, a mandrel is used for annealing the coils in the desired second operable, three dimensional shape. A
mandrel suitable for making such second operable, three dimensional shaped occlusive devices can be formed of a refractory material, such as alumina or zirconia, for example. The mandrel typically has the general three dimensional shape that the occlusive device will be given, and can have a generally helical, conical, or spherical shape, or can have a unique shape designed to provide such a primary configuration to the occlusive device. The mandrel forms a support for the winding and heat treatment of the micro-cable, plurality of microcables, or composite micro-cable occlusive device as described above, and ideally will not contaminate the occlusive device during heat treatment of the device.
In one presently preferred embodiment illustrated in Figures 13A and 13B, one or more of the flexible strands forming the vasoocciusive coil are wound around the surface of a mandrel 70 having a substantially spherical main body 72 with six cylindrical posts 74 having a diameter slightly smaller than that of the main body, disposed on the body and aligned with the three orthogonal x, y and z axes through the body of the mandrel, for aligning and shaping the distal portion of the vasoocclusive device as it is wound on the mandrel. Preferably one of the posts 76 is longer than the other posts, to serve as a mandrel for helically winding the proximal portion of the vasoocclusive coil. As is shown in Figure 14, in a presently preferred variant of the embodiment of Figures 13A and 13B, the mandre170' has a main body 72' that is substantially cubical, with the six cylindrical posts 74' disposed on each of the faces of the main body, and one of the posts 76' being longer than the others.
In another presently preferred embodiment illustrated in Figures 15A
to 15F, one or more of the flexible strands forming the vasoocclusive coil are wound around the surface of a mandrel 80 having a substantially spherical main body 82, with a plurality of circumferential grooves 84 defined on the surface of the main body, and a plurality of posts 86 mounted on the main body of the mandrel for aligning the occlusive device as it is wound on the mandrel.
In another presently preferred embodiment illustrated in Figures 16A
5 to 16E, one or more of the flexible strands forming the vasoocclusive coil are wound around the surface of a substantially spherical mandrel 90 having a plurality of circumferential grooves 92 for aligning the occlusive device as it is wound on the mandrel.
Figures 17A to 17E illustrate another presently preferred embodiment 10 of a substantially spherical mandrel 100 having a plurality of circumferential grooves 102 for aligning the occlusive device, in which one or more of the flexible strands forming the vasoocclusive coil are wound around the surface of the mandrel.
The surface of the mandrel may also have one or more apertures for receiving one or more ends of the strands, to assist winding into the desired form. The 15 wound occlusive device is preferably heat treated at a suitable temperature and a sufficient period of time to impart the form to the shape memory material included in the device. While heat treatment at a temperature of about 1100 F for approximately 4 hours ormore is typically sufficient to impart the form to the occlusive device when the shape memory material is a nickel titanium super-elastic alloy, although the 20 temperature utilized can be substantially lowered, and the duration of heat treatment adjusted accordingly, as will be appreciated by those skilled in the art.
After the heat treatment, the occlusive device is removed from the mandrel, and cold worked into the desired collapsed elongated configuration for placement into a catheter or cannula for use. When the occlusive device reaches its destination in the vasculature during vascular therapy, it assumes the primary shape imparted from the heat treatment on the mandrel.
It will be apparent from the foregoing that while particular forms of the invention have been illustrated and described, various modifications can be made without departing from the spirit and scope of the invention. Accordingly, it is not intended that the invention be limited, except as by the appended claims.
It will be appreciated that a three dimensional occlusive device adapted to be inserted into a portion of a vasculature for occluding the portion of the vasculature for use in interventional therapy and vascular surgery, can be formed as described above, from at least one multi-stranded micro-cable having a plurality of flexible strands of a resilient material, with at least one radiopaque strand to provide a radiopaque marker for the device during vascular surgery. The occlusive device is configured to have a first inoperable, substantially linear, elongated configuration for insertion into and through a catheter or cannula to a desired portion of the vasculature to be treated, and a second operable, three dimensional configuration for occluding the desired portion of the vasculature to be treated.
In the method of making the vasoocclusive coils of the invention, a mandrel is used for annealing the coils in the desired second operable, three dimensional shape. A
mandrel suitable for making such second operable, three dimensional shaped occlusive devices can be formed of a refractory material, such as alumina or zirconia, for example. The mandrel typically has the general three dimensional shape that the occlusive device will be given, and can have a generally helical, conical, or spherical shape, or can have a unique shape designed to provide such a primary configuration to the occlusive device. The mandrel forms a support for the winding and heat treatment of the micro-cable, plurality of microcables, or composite micro-cable occlusive device as described above, and ideally will not contaminate the occlusive device during heat treatment of the device.
In one presently preferred embodiment illustrated in Figures 13A and 13B, one or more of the flexible strands forming the vasoocciusive coil are wound around the surface of a mandrel 70 having a substantially spherical main body 72 with six cylindrical posts 74 having a diameter slightly smaller than that of the main body, disposed on the body and aligned with the three orthogonal x, y and z axes through the body of the mandrel, for aligning and shaping the distal portion of the vasoocclusive device as it is wound on the mandrel. Preferably one of the posts 76 is longer than the other posts, to serve as a mandrel for helically winding the proximal portion of the vasoocclusive coil. As is shown in Figure 14, in a presently preferred variant of the embodiment of Figures 13A and 13B, the mandre170' has a main body 72' that is substantially cubical, with the six cylindrical posts 74' disposed on each of the faces of the main body, and one of the posts 76' being longer than the others.
In another presently preferred embodiment illustrated in Figures 15A
to 15F, one or more of the flexible strands forming the vasoocclusive coil are wound around the surface of a mandrel 80 having a substantially spherical main body 82, with a plurality of circumferential grooves 84 defined on the surface of the main body, and a plurality of posts 86 mounted on the main body of the mandrel for aligning the occlusive device as it is wound on the mandrel.
In another presently preferred embodiment illustrated in Figures 16A
5 to 16E, one or more of the flexible strands forming the vasoocclusive coil are wound around the surface of a substantially spherical mandrel 90 having a plurality of circumferential grooves 92 for aligning the occlusive device as it is wound on the mandrel.
Figures 17A to 17E illustrate another presently preferred embodiment 10 of a substantially spherical mandrel 100 having a plurality of circumferential grooves 102 for aligning the occlusive device, in which one or more of the flexible strands forming the vasoocclusive coil are wound around the surface of the mandrel.
The surface of the mandrel may also have one or more apertures for receiving one or more ends of the strands, to assist winding into the desired form. The 15 wound occlusive device is preferably heat treated at a suitable temperature and a sufficient period of time to impart the form to the shape memory material included in the device. While heat treatment at a temperature of about 1100 F for approximately 4 hours ormore is typically sufficient to impart the form to the occlusive device when the shape memory material is a nickel titanium super-elastic alloy, although the 20 temperature utilized can be substantially lowered, and the duration of heat treatment adjusted accordingly, as will be appreciated by those skilled in the art.
After the heat treatment, the occlusive device is removed from the mandrel, and cold worked into the desired collapsed elongated configuration for placement into a catheter or cannula for use. When the occlusive device reaches its destination in the vasculature during vascular therapy, it assumes the primary shape imparted from the heat treatment on the mandrel.
It will be apparent from the foregoing that while particular forms of the invention have been illustrated and described, various modifications can be made without departing from the spirit and scope of the invention. Accordingly, it is not intended that the invention be limited, except as by the appended claims.
Claims (49)
1. ~A vasoocclusive device that is adapted to be inserted into a portion of a vasculature for occluding the portion of the vasculature for use in interventional therapy and vascular surgery, comprising:
at least one multi-stranded micro-cable formed to have a first inoperable, substantially linear configuration for insertion into and through a catheter to a desired portion of the vasculature to be treated, and a second operable, three dimensional configuration for occluding the desired part of the vasculature to be treated;
said vasoocclusive device further having a distal portion having a second operable, three dimensional shape for filling the anatomical cavity at the site in the vasculature to be treated, and a proximal portion having a second operable, substantially linear shape for filling and reinforcing the distal, three dimensional shaped portion when the vasoocclusive device is implanted at the site in the vasculature to be treated, each said multi-stranded micro-cable having a plurality of flexible strands of a resilient material comprising a central core, and at least one radiopaque strand to provide a radiopaque marker of the deployed configuration of a device made of the cable during vascular surgery.
at least one multi-stranded micro-cable formed to have a first inoperable, substantially linear configuration for insertion into and through a catheter to a desired portion of the vasculature to be treated, and a second operable, three dimensional configuration for occluding the desired part of the vasculature to be treated;
said vasoocclusive device further having a distal portion having a second operable, three dimensional shape for filling the anatomical cavity at the site in the vasculature to be treated, and a proximal portion having a second operable, substantially linear shape for filling and reinforcing the distal, three dimensional shaped portion when the vasoocclusive device is implanted at the site in the vasculature to be treated, each said multi-stranded micro-cable having a plurality of flexible strands of a resilient material comprising a central core, and at least one radiopaque strand to provide a radiopaque marker of the deployed configuration of a device made of the cable during vascular surgery.
2. ~The vasoocclusive device of claim 1, wherein said distal portion has a second operable, three dimensional shape that is substantially spherical.
3. ~The vasoocclusive device of claim 1, wherein said proximal portion is substantially linear.
4. ~The vasoocclusive device of claim 1, wherein said proximal portion is substantially helical.
5. ~The vasoocclusive device of claim 1, wherein said plurality of strands are helically wound.
6. ~The vasoocclusive device of claim 1, wherein said plurality of flexible strands are parallel longitudinal strands.
7. ~The vasoocclusive device of claim 1, wherein at least one of said plurality of strands comprises a super-elastic material.
8. ~The vasoocclusive device of claim 1, wherein said plurality of flexible strands of a resilient material are comprised of a shape memory material.
9. ~The vasoocclusive device of claim 8, wherein said shape memory material comprises a nickel-titanium alloy.
10. ~The vasoocclusive device of claim 9, wherein said shape memory nickel-titanium alloy is heat treated such that the alloy is highly flexible at a temperature appropriate for introduction into the body via a catheter, and after placement, the device will take on the primary coil configuration.
11. ~The vasoocclusive device of claim 8, wherein said shape memory material comprises a shape memory polymer.
12. ~The vasoocclusive device of claim 1, wherein said plurality of strands comprises a plurality of exterior strands surrounding at least one interior strand.
13. ~The vasoocclusive device of claim 1, wherein said plurality of strands comprises a plurality of exterior strands surrounding said central core.
14. ~The vasoocclusive device of claim 1, wherein said radiopaque strand comprises at least one centrally, axially disposed radiopaque wire.
15. ~The vasoocclusive device of claim 1, wherein said radiopaque wire is made of platinum.
16. ~The vasoocclusive device of claim 1, wherein said radiopaque wire is made of tungsten.
17. ~The vasoocclusive device of claim 1, wherein said radiopaque wire is made of gold.
18. ~The vasoocclusive device of claim 1, wherein said plurality of strands comprises a plurality of radiopaque strands.
19. ~The vasoocclusive device of claim 1, wherein said central core comprises copper.
20. ~The vasoocclusive device of claim 1, wherein said central core comprises a copper alloy.
21. ~The vasoocclusive device of claim 1, wherein said strands of the micro-cable are bundled by at least one outer cover to produce a composite banded cable.
22. ~A vasoocclusive device that is adapted to be inserted into a portion of a vasculature for occluding the portion of the vasculature for use in interventional therapy and vascular surgery, comprising:
at least one multi-stranded micro-cable formed to have a first inoperable, substantially linear configuration for insertion into and through a catheter to a desired portion of the vasculature to be treated, and a second operable, three dimensional configuration for occluding the desired part of the vasculature to be treated;
said vasoocclusive device further having a distal portion having a second operable, three dimensional shape for filling the anatomical cavity at the site in the vasculature to be treated, and a proximal portion having a second operable, substantially linear shape for filling and reinforcing the distal, three dimensional shaped portion when the vasoocclusive device is implanted at the site in the vasculature to be treated, each said multi-stranded micro-cable having a plurality of flexible strands of a resilient material comprising a central core, and at least one radiopaque strand to provide a radiopaque marker of the deployed configuration of a device made of the cable during vascular surgery, and wherein said strands of the micro-cable are bundled by a least one outer cover comprising a sheath to constrain said strands about a longitudinal axis to produce a composite banded cable.
at least one multi-stranded micro-cable formed to have a first inoperable, substantially linear configuration for insertion into and through a catheter to a desired portion of the vasculature to be treated, and a second operable, three dimensional configuration for occluding the desired part of the vasculature to be treated;
said vasoocclusive device further having a distal portion having a second operable, three dimensional shape for filling the anatomical cavity at the site in the vasculature to be treated, and a proximal portion having a second operable, substantially linear shape for filling and reinforcing the distal, three dimensional shaped portion when the vasoocclusive device is implanted at the site in the vasculature to be treated, each said multi-stranded micro-cable having a plurality of flexible strands of a resilient material comprising a central core, and at least one radiopaque strand to provide a radiopaque marker of the deployed configuration of a device made of the cable during vascular surgery, and wherein said strands of the micro-cable are bundled by a least one outer cover comprising a sheath to constrain said strands about a longitudinal axis to produce a composite banded cable.
23. ~The vasoocclusive device of claim 22, wherein said outer cover comprises an outer sheath of material to provide bending stiffness and constrain said strands about said longitudinal axis.
24. ~The vasoocclusive device of claim 23, wherein said sheath comprises a containment strand wound about said longitudinal strands.
25. ~The vasoocclusive device of claim 23, wherein said sheath is made of low friction material.
26. ~The vasoocclusive device of claim 23, wherein said sheath is made of a fluoropolymer.
27. ~The vasoocclusive device of claim 23, wherein said sheath comprises a heat shrinkable plastic tube.
28. ~The vasoocclusive device of claim 21, wherein said strands are bundled by a plurality of bands disposed at intervals to produce a composite banded cable.
29. ~The vasoocclusive device of claim 28, wherein said strands are laid parallel within the composite banded cable.
30. ~The vasoocclusive device of claim 28, wherein said strands are twisted within the composite banded cable.
31. ~The vasoocclusive device of claim 28, wherein composite cable comprises a single inner micro-cable.
32. ~The vasoocclusive device of claim 28, wherein said exterior wrapped cover is wound at varying intervals along the outside to provide variations in the torqueability and stiffness of the composite cable.
33. ~The vasoocclusive device of claim 32, wherein the width of the outer cover is varied along the composite cable.
34. ~The vasoocclusive device of claim 28, wherein said outer covering varies in cross section along its length to provide bending stiffness of said composite cable which varies along said composite cable.
35. ~The vasoocclusive device of claim 21, wherein the number of strands and the degree to which they extend along said composite cable within the outer covering varies along said composite cable.
36. ~The vasoocclusive device of claim 23, wherein outer covering comprises a plurality of layers formed of different materials in order to provide a graduated bending and stiffness characteristic.
37. ~The vasoocclusive device of claim 28, wherein said composite microcable comprises a plurality of micro-cables disposed within said outer cover in order to provide desired bending and strength characteristics.
38. ~The vasoocclusive device of claim 35, wherein said plurality of micro-cables are helically wound within said outer cover.
39. ~The vasoocclusive device of claim 35, wherein said plurality of micro-cables extend parallel and longitudinally within said outer cover.
40. ~The vasoocclusive device of claim 35, wherein said plurality of micro-cables are bundled by at least one outer cover to produce said composite banded cable.
41. ~The vasoocclusive device of claim 40, wherein said plurality of micro-cables are banded at intervals by a plurality of bands.
42. ~A method of making a vasoocclusive device that is adapted to be inserted into a portion of a vasculature for occluding the portion of the vasculature for use in interventional therapy and vascular surgery, said vasoocclusive device being formed from at least one strand of a flexible shape memory material formed to have a first inoperable, substantially linear configuration for insertion into and through a catheter to a desired portion of the vasculature to be treated, and a second operable, three dimensional configuration for occluding the desired portion of the vasculature to be treated, said vasoocclusive device having a distal portion having a second operable, three dimensionally shape, and a proximal portion having a second operable, substantially linear shape, the method comprising the steps of:
winding at least one strand of a flexible shape memory material about a mandrel in a three dimensional configuration of the vasoocclusive coil to form a distal portion of the vasoocclusive coil;
heating said at least one strand of a flexible shape memory material wound about the mandrel for a sufficient period of time to impart the form to the shape memory material included in the device to form an operable, three dimensional configuration of the vasoocclusive coil;
removing the vasoocclusive coil from the mandrel; and cold working the vasoocclusive coil into a desired elongated configuration for placement into a catheter or cannula for use.
winding at least one strand of a flexible shape memory material about a mandrel in a three dimensional configuration of the vasoocclusive coil to form a distal portion of the vasoocclusive coil;
heating said at least one strand of a flexible shape memory material wound about the mandrel for a sufficient period of time to impart the form to the shape memory material included in the device to form an operable, three dimensional configuration of the vasoocclusive coil;
removing the vasoocclusive coil from the mandrel; and cold working the vasoocclusive coil into a desired elongated configuration for placement into a catheter or cannula for use.
43. ~The method of claim 42, wherein the mandrel about which said at least one flexible strand forming the vasoocclusive coil is wound has a substantially spherical body portion having a plurality of circumferential grooves to form a three dimensional configuration of a distal portion of the vasoocclusive coil.
44. ~The method of claim 42, wherein the mandrel about which said at least one flexible strand forming the vasoocclusive coil is wound has a main body with a plurality of posts disposed on the body.
45. ~The method of claim 44, wherein six posts are disposed on the body aligned with the three orthogonal x, y and z axes through the body of the mandrel, for aligning and shaping the distal portion of the vasoocclusive device as it is wound on the mandrel.
46. ~The method of claim 44, wherein one of the posts is longer than the other posts, to serve as a mandrel for helically winding the proximal portion of the vasoocclusive coil.
47. ~The method of claim 44, wherein said main body is substantially spherical.
48. ~The method of claim 44, wherein said main body is substantially cubical.
49. ~The method of claim 42, wherein the step of heating comprises heating said at least one strand of a flexible shape memory material wound about a mandrel made of refractory material at a temperature of about 1100° F. for about at least 4 hours.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/140,495 US6171326B1 (en) | 1998-08-27 | 1998-08-27 | Three dimensional, low friction vasoocclusive coil, and method of manufacture |
| US09/140,495 | 1998-08-27 | ||
| PCT/US1999/020391 WO2000012016A1 (en) | 1998-08-27 | 1999-08-27 | Three dimensional, low friction vasoocclusive coil, and method of manufacture |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2341704A1 CA2341704A1 (en) | 2000-03-09 |
| CA2341704C true CA2341704C (en) | 2008-07-08 |
Family
ID=22491491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002341704A Expired - Lifetime CA2341704C (en) | 1998-08-27 | 1999-08-27 | Three dimensional, low friction vasoocclusive coil, and method of manufacture |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6171326B1 (en) |
| EP (1) | EP1105054B1 (en) |
| JP (1) | JP4065665B2 (en) |
| KR (1) | KR100621819B1 (en) |
| AT (1) | ATE380504T1 (en) |
| AU (1) | AU748677B2 (en) |
| BR (1) | BR9913287A (en) |
| CA (1) | CA2341704C (en) |
| DE (1) | DE69937740T2 (en) |
| ES (1) | ES2297935T3 (en) |
| NO (1) | NO20010955L (en) |
| WO (1) | WO2000012016A1 (en) |
Families Citing this family (93)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6638291B1 (en) * | 1995-04-20 | 2003-10-28 | Micrus Corporation | Three dimensional, low friction vasoocclusive coil, and method of manufacture |
| US6511468B1 (en) | 1997-10-17 | 2003-01-28 | Micro Therapeutics, Inc. | Device and method for controlling injection of liquid embolic composition |
| US6159165A (en) * | 1997-12-05 | 2000-12-12 | Micrus Corporation | Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand |
| US7070607B2 (en) | 1998-01-27 | 2006-07-04 | The Regents Of The University Of California | Bioabsorbable polymeric implants and a method of using the same to create occlusions |
| US7018401B1 (en) | 1999-02-01 | 2006-03-28 | Board Of Regents, The University Of Texas System | Woven intravascular devices and methods for making the same and apparatus for delivery of the same |
| US7033374B2 (en) * | 2000-09-26 | 2006-04-25 | Microvention, Inc. | Microcoil vaso-occlusive device with multi-axis secondary configuration |
| US7029486B2 (en) * | 2000-09-26 | 2006-04-18 | Microvention, Inc. | Microcoil vaso-occlusive device with multi-axis secondary configuration |
| US6605101B1 (en) * | 2000-09-26 | 2003-08-12 | Microvention, Inc. | Microcoil vaso-occlusive device with multi-axis secondary configuration |
| US6635069B1 (en) * | 2000-10-18 | 2003-10-21 | Scimed Life Systems, Inc. | Non-overlapping spherical three-dimensional coil |
| US6589265B1 (en) * | 2000-10-31 | 2003-07-08 | Endovascular Technologies, Inc. | Intrasaccular embolic device |
| EP1545705A4 (en) | 2000-11-16 | 2010-04-28 | Microspherix Llc | Flexible and/or elastic brachytherapy seed or strand |
| US7640952B2 (en) | 2001-06-28 | 2010-01-05 | Lithotech Medical Ltd. | Method for manufacturing a surgical device for extracting a foreign object |
| US20040006362A1 (en) * | 2002-07-02 | 2004-01-08 | Dean Schaefer | Uniaxial multifilar vaso-occlusive device with high stretch resistance and low buckling strength |
| US20040006354A1 (en) * | 2002-07-02 | 2004-01-08 | Dean Schaefer | Coaxial stretch-resistant vaso-occlusive device |
| US20050171572A1 (en) * | 2002-07-31 | 2005-08-04 | Microvention, Inc. | Multi-layer coaxial vaso-occlusive device |
| CN101919722A (en) | 2002-07-31 | 2010-12-22 | 微温森公司 | The vascular occluding device of three-part coaxial |
| US7981862B2 (en) | 2003-08-19 | 2011-07-19 | Biosurface Engineering Technologies, Inc. | Composition comprising BMP-2 amplifier/co-activator for enhancement of osteogenesis |
| US7598224B2 (en) * | 2002-08-20 | 2009-10-06 | Biosurface Engineering Technologies, Inc. | Dual chain synthetic heparin-binding growth factor analogs |
| US8227411B2 (en) * | 2002-08-20 | 2012-07-24 | BioSurface Engineering Technologies, Incle | FGF growth factor analogs |
| US8758372B2 (en) | 2002-08-29 | 2014-06-24 | St. Jude Medical, Cardiology Division, Inc. | Implantable devices for controlling the size and shape of an anatomical structure or lumen |
| EP1531762B1 (en) | 2002-08-29 | 2010-04-14 | St. Jude Medical, Cardiology Division, Inc. | Implantable devices for controlling the internal circumference of an anatomic orifice or lumen |
| US20040193072A1 (en) * | 2003-03-28 | 2004-09-30 | Allen John J. | Method of analyte measurement using integrated lance and strip |
| US8043321B2 (en) * | 2003-07-24 | 2011-10-25 | Boston Scientific Scimed, Inc. | Embolic coil |
| US20050107823A1 (en) * | 2003-11-19 | 2005-05-19 | Leone Jim E. | Anchored stent and occlusive device for treatment of aneurysms |
| JP2005185386A (en) * | 2003-12-25 | 2005-07-14 | Asahi Intecc Co Ltd | Medical guide wire |
| JP4895826B2 (en) | 2004-02-20 | 2012-03-14 | バイオサーフェス エンジニアリング テクノロジーズ，インク． | Bone morphogenetic protein-2 positive modulator |
| TWI434676B (en) | 2004-03-19 | 2014-04-21 | Merck Sharp & Dohme | X-ray visible drug delivery device |
| US20050267510A1 (en) * | 2004-05-26 | 2005-12-01 | Nasser Razack | Device for the endovascular treatment of intracranial aneurysms |
| KR101033123B1 (en) * | 2004-06-30 | 2011-05-11 | 엘지디스플레이 주식회사 | chamber type apparatus for liquid crystal display device |
| US7879064B2 (en) * | 2004-09-22 | 2011-02-01 | Micro Therapeutics, Inc. | Medical implant |
| EP1793743B1 (en) | 2004-09-22 | 2009-11-18 | Dendron GmbH | Micro-spiral implantation device |
| US8535345B2 (en) * | 2004-10-07 | 2013-09-17 | DePuy Synthes Products, LLC | Vasoocclusive coil with biplex windings to improve mechanical properties |
| JP2008519613A (en) * | 2004-11-09 | 2008-06-12 | ボストン サイエンティフィック リミテッド | Vascular occlusion device with composite shaped proximal portion and smaller diameter distal |
| EP2626039B1 (en) | 2005-03-25 | 2015-10-14 | St. Jude Medical, Cardiology Division, Inc. | Apparatus for controlling the internal circumference of an anatomic orifice or lumen |
| US8864823B2 (en) | 2005-03-25 | 2014-10-21 | StJude Medical, Cardiology Division, Inc. | Methods and apparatus for controlling the internal circumference of an anatomic orifice or lumen |
| US8467854B2 (en) * | 2005-04-20 | 2013-06-18 | Scimed Life Systems, Inc. | Neurovascular intervention device |
| US8066036B2 (en) | 2005-11-17 | 2011-11-29 | Microvention, Inc. | Three-dimensional complex coil |
| JP5230602B2 (en) | 2006-04-17 | 2013-07-10 | タイコ ヘルスケア グループ リミテッド パートナーシップ | System and method for mechanically positioning an endovascular implant |
| US8777979B2 (en) | 2006-04-17 | 2014-07-15 | Covidien Lp | System and method for mechanically positioning intravascular implants |
| MX2008014769A (en) * | 2006-05-19 | 2009-07-02 | Mitralsolutions Inc | Implantable devices for controlling the size and shape of an anatomical structure or lumen. |
| BRPI0711784B8 (en) | 2006-06-15 | 2021-06-22 | Microvention Inc | embolization device constructed of expandable polymer and its method of preparation |
| KR101659197B1 (en) | 2006-10-22 | 2016-09-22 | 이데브 테크놀로지스, 아이엔씨. | Devices and methods for stent advancement |
| CA2667318C (en) | 2006-10-22 | 2016-09-13 | Idev Technologies, Inc. | Methods for securing strand ends and the resulting devices |
| US9107750B2 (en) | 2007-01-03 | 2015-08-18 | St. Jude Medical, Cardiology Division, Inc. | Implantable devices for controlling the size and shape of an anatomical structure or lumen |
| US20090254112A1 (en) * | 2007-02-07 | 2009-10-08 | Micrus Endovascular Corporation | Winding mandrel for vasoocclusive coils |
| JP5249249B2 (en) * | 2007-03-13 | 2013-07-31 | コヴィディエン リミテッド パートナーシップ | Implant including a coil and a stretch resistant member |
| KR20100015521A (en) * | 2007-03-13 | 2010-02-12 | 마이크로 테라퓨틱스 인코포레이티드 | An implant, a mandrel, and a method of forming an implant |
| US8870908B2 (en) * | 2007-08-17 | 2014-10-28 | DePuy Synthes Products, LLC | Twisted primary coil for vascular therapy |
| US8968382B2 (en) | 2007-12-11 | 2015-03-03 | Cornell University | Method and apparatus for restricting flow through an opening in the side wall |
| WO2009076515A1 (en) * | 2007-12-11 | 2009-06-18 | Cornell University | Method and apparatus for sealing an opening in the side wall of a body lumen |
| CA2709379C (en) | 2007-12-21 | 2016-08-16 | Microvention, Inc. | Hydrogel filaments for biomedical uses |
| WO2009124148A1 (en) * | 2008-04-04 | 2009-10-08 | Curaseal, Inc. | Implantable fistula closure device |
| US20090318948A1 (en) * | 2008-04-22 | 2009-12-24 | Coherex Medical, Inc. | Device, system and method for aneurysm embolization |
| EP3045123B1 (en) | 2008-06-16 | 2020-04-08 | University Of Rochester | Compositions comprising a combination of fibroblast growth factor (fgf) analogs with thrombopoietin for use for treating acute radiation syndrome |
| CA2732507A1 (en) | 2008-08-06 | 2010-02-11 | Boston Scientific Scimed, Inc. | Vaso-occlusive devices with textured surfaces |
| KR101643371B1 (en) | 2008-08-19 | 2016-07-27 | 마이크로 테라퓨틱스 인코포레이티드 | Detachable tip microcatheter |
| JP5374967B2 (en) * | 2008-08-27 | 2013-12-25 | 株式会社カネカ | Vessel occlusion device and method for manufacturing the same |
| CN102202582B (en) | 2008-09-04 | 2014-07-30 | 库拉希尔公司 | Inflatable device for enteric fistula treatment |
| US8470013B2 (en) * | 2008-10-20 | 2013-06-25 | Imds Corporation | Systems and methods for aneurysm treatment and vessel occlusion |
| US8808371B2 (en) | 2009-01-22 | 2014-08-19 | St. Jude Medical, Cardiology Division, Inc. | Post-operative adjustment tool, minimally invasive attachment apparatus, and adjustable tricuspid ring |
| EP2389141B1 (en) * | 2009-01-22 | 2018-12-26 | Cornell University | Apparatus for restricting flow through the wall of a lumen |
| US10639396B2 (en) | 2015-06-11 | 2020-05-05 | Microvention, Inc. | Polymers |
| US20120071911A1 (en) * | 2009-05-20 | 2012-03-22 | University Of Miami | Spherical helix embolic coils for the treatment of cerebral aneurysms |
| JP2013505791A (en) * | 2009-09-24 | 2013-02-21 | マイクロベンション インコーポレイテッド | Injectable hydrogel fiber for medical use |
| KR101745748B1 (en) * | 2009-10-26 | 2017-06-12 | 마이크로벤션, 인코포레이티드 | Embolization device constructed from expansile polymer |
| US9023095B2 (en) | 2010-05-27 | 2015-05-05 | Idev Technologies, Inc. | Stent delivery system with pusher assembly |
| EP2693981A4 (en) | 2011-04-01 | 2015-07-01 | Univ Cornell | Method and apparatus for restricting flow through an opening in the side wall of a body lumen, and/or for reinforcing a weakness in the side wall of a body lumen, while still maintaining substantially normal flow through the body lumen |
| US9456823B2 (en) | 2011-04-18 | 2016-10-04 | Terumo Corporation | Embolic devices |
| US9211116B2 (en) | 2011-06-16 | 2015-12-15 | Curaseal Inc. | Fistula treatment devices and related methods |
| JP6127042B2 (en) | 2011-06-17 | 2017-05-10 | キュラシール インコーポレイテッド | Device and method for fistula treatment |
| US9579104B2 (en) | 2011-11-30 | 2017-02-28 | Covidien Lp | Positioning and detaching implants |
| US9011480B2 (en) * | 2012-01-20 | 2015-04-21 | Covidien Lp | Aneurysm treatment coils |
| US9687245B2 (en) | 2012-03-23 | 2017-06-27 | Covidien Lp | Occlusive devices and methods of use |
| WO2013158781A1 (en) | 2012-04-18 | 2013-10-24 | Microvention, Inc. | Embolic devices |
| US10124087B2 (en) | 2012-06-19 | 2018-11-13 | Covidien Lp | Detachable coupling for catheter |
| JP5958158B2 (en) * | 2012-08-02 | 2016-07-27 | 株式会社カネカ | Method for producing in-vivo indwelling member and shaping mold used therefor |
| AU2015222866A1 (en) | 2014-02-27 | 2016-09-15 | Incumedx, Inc. | Embolic framing microcoils |
| WO2015153996A1 (en) | 2014-04-03 | 2015-10-08 | Micro Vention, Inc. | Embolic devices |
| US9713475B2 (en) | 2014-04-18 | 2017-07-25 | Covidien Lp | Embolic medical devices |
| JP6599361B2 (en) | 2014-04-29 | 2019-10-30 | マイクロベンション インコーポレイテッド | Polymer containing an active agent |
| US10092663B2 (en) | 2014-04-29 | 2018-10-09 | Terumo Corporation | Polymers |
| US10709453B2 (en) | 2014-05-19 | 2020-07-14 | Kaneka Corporation | In vivo indwelling member and method for producing same |
| JP6601880B2 (en) | 2014-07-25 | 2019-11-06 | インキュメデックス インコーポレイテッド | Coated embolic coil |
| KR20170101937A (en) * | 2014-12-11 | 2017-09-06 | 오콘 메디컬 엘티디. | Device positionable in the uterine cavity |
| US10857012B2 (en) | 2015-01-20 | 2020-12-08 | Neurogami Medical, Inc. | Vascular implant |
| US11484319B2 (en) | 2015-01-20 | 2022-11-01 | Neurogami Medical, Inc. | Delivery system for micrograft for treating intracranial aneurysms |
| US10736730B2 (en) | 2015-01-20 | 2020-08-11 | Neurogami Medical, Inc. | Vascular implant |
| US10925611B2 (en) | 2015-01-20 | 2021-02-23 | Neurogami Medical, Inc. | Packaging for surgical implant |
| WO2016118420A1 (en) | 2015-01-20 | 2016-07-28 | Neurogami Medical, Inc. | Micrograft for the treatment of intracranial aneurysms and method for use |
| US10307168B2 (en) | 2015-08-07 | 2019-06-04 | Terumo Corporation | Complex coil and manufacturing techniques |
| JP6757330B2 (en) | 2015-11-19 | 2020-09-16 | 株式会社カネカ | In-vivo indwelling member and in-vivo indwelling member arranging device including the in-vivo indwelling member |
| US10420563B2 (en) | 2016-07-08 | 2019-09-24 | Neurogami Medical, Inc. | Delivery system insertable through body lumen |
| CN112741691B (en) * | 2020-12-31 | 2022-05-13 | 杭州脉流科技有限公司 | Spring coil coiled support release simulation method and device, computer equipment and storage medium |
Family Cites Families (103)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1667730A (en) | 1928-05-01 | of chicago | ||
| US1341052A (en) | 1916-06-15 | 1920-05-25 | Francis G Gale | Chain |
| FR592182A (en) | 1924-03-24 | 1925-07-28 | Urethral probe | |
| US2078182A (en) | 1935-08-09 | 1937-04-20 | Sirian Wire And Contact Compan | Tungsten manufacture |
| US2549335A (en) | 1947-04-18 | 1951-04-17 | Rahthus Max | Ornamental chain |
| US3334629A (en) | 1964-11-09 | 1967-08-08 | Bertram D Cohn | Occlusive device for inferior vena cava |
| US3649224A (en) | 1968-04-18 | 1972-03-14 | Sylvania Electric Prod | Method of making nonsag filaments for electric lamps |
| US3868956A (en) | 1972-06-05 | 1975-03-04 | Ralph J Alfidi | Vessel implantable appliance and method of implanting it |
| GB2066839B (en) | 1979-12-29 | 1984-03-14 | Vysoka Skola Chem Tech | Method of manufacture of perfumed detergents |
| SE445884B (en) | 1982-04-30 | 1986-07-28 | Medinvent Sa | DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION |
| US4638803A (en) | 1982-09-30 | 1987-01-27 | Rand Robert W | Medical apparatus for inducing scar tissue formation in a body |
| US4494531A (en) | 1982-12-06 | 1985-01-22 | Cook, Incorporated | Expandable blood clot filter |
| US4531933A (en) | 1982-12-07 | 1985-07-30 | C. R. Bard, Inc. | Helical ureteral stent |
| US4512338A (en) * | 1983-01-25 | 1985-04-23 | Balko Alexander B | Process for restoring patency to body vessels |
| EP0183372A1 (en) | 1984-10-19 | 1986-06-04 | RAYCHEM CORPORATION (a Delaware corporation) | Prosthetic stent |
| US4718907A (en) | 1985-06-20 | 1988-01-12 | Atrium Medical Corporation | Vascular prosthesis having fluorinated coating with varying F/C ratio |
| US4748986A (en) | 1985-11-26 | 1988-06-07 | Advanced Cardiovascular Systems, Inc. | Floppy guide wire with opaque tip |
| EP0556940A1 (en) | 1986-02-24 | 1993-08-25 | Robert E. Fischell | Intravascular stent |
| US4800882A (en) | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
| US4813925A (en) | 1987-04-21 | 1989-03-21 | Medical Engineering Corporation | Spiral ureteral stent |
| US4795458A (en) | 1987-07-02 | 1989-01-03 | Regan Barrie F | Stent for use following balloon angioplasty |
| US4850960A (en) | 1987-07-08 | 1989-07-25 | Joseph Grayzel | Diagonally tapered, bevelled tip introducing catheter and sheath and method for insertion |
| US5133732A (en) | 1987-10-19 | 1992-07-28 | Medtronic, Inc. | Intravascular stent |
| US4820298A (en) | 1987-11-20 | 1989-04-11 | Leveen Eric G | Internal vascular prosthesis |
| FR2632864B2 (en) | 1987-12-31 | 1990-10-19 | Biomat Sarl | ANTI-EMBOLIC ELASTIC FILTERING SYSTEM FOR CELLAR VEIN AND ASSEMBLY OF MEANS FOR ITS PLACEMENT |
| US4830003A (en) | 1988-06-17 | 1989-05-16 | Wolff Rodney G | Compressive stent and delivery system |
| US4832055A (en) | 1988-07-08 | 1989-05-23 | Palestrant Aubrey M | Mechanically locking blood clot filter |
| US5176661A (en) | 1988-09-06 | 1993-01-05 | Advanced Cardiovascular Systems, Inc. | Composite vascular catheter |
| US4957479A (en) | 1988-10-17 | 1990-09-18 | Vance Products Incorporated | Indwelling ureteral stent placement apparatus |
| US4994069A (en) * | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
| US5203772A (en) | 1989-01-09 | 1993-04-20 | Pilot Cardiovascular Systems, Inc. | Steerable medical device |
| US4856516A (en) | 1989-01-09 | 1989-08-15 | Cordis Corporation | Endovascular stent apparatus and method |
| US4990155A (en) | 1989-05-19 | 1991-02-05 | Wilkoff Howard M | Surgical stent method and apparatus |
| DE9010130U1 (en) | 1989-07-13 | 1990-09-13 | American Medical Systems, Inc., Minnetonka, Minn., Us | |
| CA2026604A1 (en) | 1989-10-02 | 1991-04-03 | Rodney G. Wolff | Articulated stent |
| DE4102550A1 (en) | 1990-02-02 | 1991-08-08 | Stephan Prof Dr Bockenheimer | Sealing blood vessel fistula - involves inserted sleeve with spiral support with turns bridged by impervious elastic material |
| ATE120377T1 (en) | 1990-02-08 | 1995-04-15 | Howmedica | INFLATABLE DILATATOR. |
| US5186992A (en) | 1990-03-12 | 1993-02-16 | The Bentley-Harris Manufacturing Company | Braided product and method of making same |
| US5122136A (en) | 1990-03-13 | 1992-06-16 | The Regents Of The University Of California | Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
| US5354295A (en) | 1990-03-13 | 1994-10-11 | Target Therapeutics, Inc. | In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
| US5569245A (en) | 1990-03-13 | 1996-10-29 | The Regents Of The University Of California | Detachable endovascular occlusion device activated by alternating electric current |
| US5071407A (en) | 1990-04-12 | 1991-12-10 | Schneider (U.S.A.) Inc. | Radially expandable fixation member |
| US5108407A (en) | 1990-06-08 | 1992-04-28 | Rush-Presbyterian St. Luke's Medical Center | Method and apparatus for placement of an embolic coil |
| US5064435A (en) | 1990-06-28 | 1991-11-12 | Schneider (Usa) Inc. | Self-expanding prosthesis having stable axial length |
| US5041084A (en) | 1990-08-09 | 1991-08-20 | Dlp, Inc. | Single stage venous catheter |
| US5176625A (en) | 1990-10-25 | 1993-01-05 | Brisson A Glen | Stent for ureter |
| US5160341A (en) | 1990-11-08 | 1992-11-03 | Advanced Surgical Intervention, Inc. | Resorbable urethral stent and apparatus for its insertion |
| US5133731A (en) | 1990-11-09 | 1992-07-28 | Catheter Research, Inc. | Embolus supply system and method |
| DE4104702C2 (en) | 1991-02-15 | 1996-01-18 | Malte Neuss | Implants for organ pathways in spiral form |
| US5228453A (en) | 1991-05-07 | 1993-07-20 | Target Therapeutics, Inc. | Catheter guide wire |
| US5217484A (en) | 1991-06-07 | 1993-06-08 | Marks Michael P | Retractable-wire catheter device and method |
| US5147370A (en) | 1991-06-12 | 1992-09-15 | Mcnamara Thomas O | Nitinol stent for hollow body conduits |
| US5314472A (en) | 1991-10-01 | 1994-05-24 | Cook Incorporated | Vascular stent |
| US5527354A (en) | 1991-06-28 | 1996-06-18 | Cook Incorporated | Stent formed of half-round wire |
| US5141502A (en) | 1991-08-28 | 1992-08-25 | Macaluso Jr Joseph N | Ureteral stent |
| US5183085A (en) | 1991-09-27 | 1993-02-02 | Hans Timmermans | Method and apparatus for compressing a stent prior to insertion |
| US5226911A (en) | 1991-10-02 | 1993-07-13 | Target Therapeutics | Vasoocclusion coil with attached fibrous element(s) |
| US5304194A (en) | 1991-10-02 | 1994-04-19 | Target Therapeutics | Vasoocclusion coil with attached fibrous element(s) |
| US5151105A (en) | 1991-10-07 | 1992-09-29 | Kwan Gett Clifford | Collapsible vessel sleeve implant |
| US5261916A (en) | 1991-12-12 | 1993-11-16 | Target Therapeutics | Detachable pusher-vasoocclusive coil assembly with interlocking ball and keyway coupling |
| ATE187053T1 (en) | 1991-12-12 | 1999-12-15 | Target Therapeutics Inc | UNCOUPLING, SLIDING, VESSEL-OCCLOSING SPIRAL WITH INTERLOCKING COUPLING ELEMENTS |
| US5222969A (en) | 1992-03-16 | 1993-06-29 | Rolando Gillis | Intravascular stent for cardiovascular intervention |
| US5370683A (en) | 1992-03-25 | 1994-12-06 | Cook Incorporated | Vascular stent |
| US5342387A (en) | 1992-06-18 | 1994-08-30 | American Biomed, Inc. | Artificial support for a blood vessel |
| US5443478A (en) | 1992-09-02 | 1995-08-22 | Board Of Regents, The University Of Texas System | Multi-element intravascular occlusion device |
| US5312415A (en) | 1992-09-22 | 1994-05-17 | Target Therapeutics, Inc. | Assembly for placement of embolic coils using frictional placement |
| US5350397A (en) | 1992-11-13 | 1994-09-27 | Target Therapeutics, Inc. | Axially detachable embolic coil assembly |
| US5250071A (en) | 1992-09-22 | 1993-10-05 | Target Therapeutics, Inc. | Detachable embolic coil assembly using interlocking clasps and method of use |
| US5382259A (en) | 1992-10-26 | 1995-01-17 | Target Therapeutics, Inc. | Vasoocclusion coil with attached tubular woven or braided fibrous covering |
| US5690666A (en) | 1992-11-18 | 1997-11-25 | Target Therapeutics, Inc. | Ultrasoft embolism coils and process for using them |
| US5645082A (en) | 1993-01-29 | 1997-07-08 | Cardima, Inc. | Intravascular method and system for treating arrhythmia |
| US5336205A (en) | 1993-02-25 | 1994-08-09 | Target Therapeutics, Inc. | Flow directed catheter |
| US5334210A (en) | 1993-04-09 | 1994-08-02 | Cook Incorporated | Vascular occlusion assembly |
| IL105828A (en) | 1993-05-28 | 1999-06-20 | Medinol Ltd | Medical stent |
| US5423829A (en) | 1993-11-03 | 1995-06-13 | Target Therapeutics, Inc. | Electrolytically severable joint for endovascular embolic devices |
| US5624449A (en) | 1993-11-03 | 1997-04-29 | Target Therapeutics | Electrolytically severable joint for endovascular embolic devices |
| US5441516A (en) | 1994-03-03 | 1995-08-15 | Scimed Lifesystems Inc. | Temporary stent |
| ATE295127T1 (en) | 1994-03-03 | 2005-05-15 | Boston Scient Ltd | DEVICE FOR DETECTING THE DIVISION OF A VASS OCCLUSION DEVICE |
| IL108832A (en) | 1994-03-03 | 1999-12-31 | Medinol Ltd | Urological stent and deployment device therefor |
| US5417708A (en) | 1994-03-09 | 1995-05-23 | Cook Incorporated | Intravascular treatment system and percutaneous release mechanism therefor |
| US5549624A (en) | 1994-06-24 | 1996-08-27 | Target Therapeutics, Inc. | Fibered vasooclusion coils |
| US5725546A (en) | 1994-06-24 | 1998-03-10 | Target Therapeutics, Inc. | Detachable microcoil delivery catheter |
| US5522836A (en) | 1994-06-27 | 1996-06-04 | Target Therapeutics, Inc. | Electrolytically severable coil assembly with movable detachment point |
| US5725552A (en) | 1994-07-08 | 1998-03-10 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
| US5690671A (en) | 1994-12-13 | 1997-11-25 | Micro Interventional Systems, Inc. | Embolic elements and methods and apparatus for their delivery |
| US5637113A (en) | 1994-12-13 | 1997-06-10 | Advanced Cardiovascular Systems, Inc. | Polymer film for wrapping a stent structure |
| US5514176A (en) | 1995-01-20 | 1996-05-07 | Vance Products Inc. | Pull apart coil stent |
| ES2185746T3 (en) | 1995-03-30 | 2003-05-01 | Boston Scient Ltd | SYSTEM FOR THE IMPLANT OF LIQUID COILS WITH SECONDARY STRUCTURE. |
| US5645558A (en) | 1995-04-20 | 1997-07-08 | Medical University Of South Carolina | Anatomically shaped vasoocclusive device and method of making the same |
| US5639277A (en) | 1995-04-28 | 1997-06-17 | Target Therapeutics, Inc. | Embolic coils with offset helical and twisted helical shapes |
| US5624461A (en) * | 1995-06-06 | 1997-04-29 | Target Therapeutics, Inc. | Three dimensional in-filling vaso-occlusive coils |
| US5766160A (en) | 1995-06-06 | 1998-06-16 | Target Therapeutics, Inc. | Variable stiffness coils |
| NO962336L (en) | 1995-06-06 | 1996-12-09 | Target Therapeutics Inc | Vaso-occlusive spiral |
| US5707389A (en) * | 1995-06-07 | 1998-01-13 | Baxter International Inc. | Side branch occlusion catheter device having integrated endoscope for performing endoscopically visualized occlusion of the side branches of an anatomical passageway |
| US5582619A (en) | 1995-06-30 | 1996-12-10 | Target Therapeutics, Inc. | Stretch resistant vaso-occlusive coils |
| CA2186768C (en) * | 1995-09-29 | 2000-12-12 | Pete Phong Pham | Anatomically shaped vasoocclusive devices |
| AU690862B2 (en) * | 1995-12-04 | 1998-04-30 | Target Therapeutics, Inc. | Fibered micro vaso-occlusive devices |
| US5749894A (en) * | 1996-01-18 | 1998-05-12 | Target Therapeutics, Inc. | Aneurysm closure method |
| US5690643A (en) | 1996-02-20 | 1997-11-25 | Leocor, Incorporated | Stent delivery system |
| US5649949A (en) | 1996-03-14 | 1997-07-22 | Target Therapeutics, Inc. | Variable cross-section conical vasoocclusive coils |
| US5676697A (en) | 1996-07-29 | 1997-10-14 | Cardiovascular Dynamics, Inc. | Two-piece, bifurcated intraluminal graft for repair of aneurysm |
| DK177010B1 (en) * | 1996-09-03 | 2010-11-29 | Cook William Europ | Embolization device for placement in a blood vessel |
| US5733329A (en) | 1996-12-30 | 1998-03-31 | Target Therapeutics, Inc. | Vaso-occlusive coil with conical end |
-
1998
- 1998-08-27 US US09/140,495 patent/US6171326B1/en not_active Expired - Lifetime
-
1999
- 1999-08-27 BR BR9913287-7A patent/BR9913287A/en not_active Application Discontinuation
- 1999-08-27 CA CA002341704A patent/CA2341704C/en not_active Expired - Lifetime
- 1999-08-27 AT AT99945520T patent/ATE380504T1/en not_active IP Right Cessation
- 1999-08-27 KR KR1020017002493A patent/KR100621819B1/en not_active IP Right Cessation
- 1999-08-27 AU AU58106/99A patent/AU748677B2/en not_active Ceased
- 1999-08-27 DE DE69937740T patent/DE69937740T2/en not_active Expired - Lifetime
- 1999-08-27 JP JP2000567143A patent/JP4065665B2/en not_active Expired - Fee Related
- 1999-08-27 ES ES99945520T patent/ES2297935T3/en not_active Expired - Lifetime
- 1999-08-27 EP EP99945520A patent/EP1105054B1/en not_active Expired - Lifetime
- 1999-08-27 WO PCT/US1999/020391 patent/WO2000012016A1/en active IP Right Grant
-
2001
- 2001-02-26 NO NO20010955A patent/NO20010955L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE380504T1 (en) | 2007-12-15 |
| BR9913287A (en) | 2001-05-15 |
| KR100621819B1 (en) | 2006-09-13 |
| ES2297935T3 (en) | 2008-05-01 |
| JP4065665B2 (en) | 2008-03-26 |
| EP1105054A1 (en) | 2001-06-13 |
| US6171326B1 (en) | 2001-01-09 |
| JP2002523172A (en) | 2002-07-30 |
| WO2000012016A9 (en) | 2000-10-05 |
| CA2341704A1 (en) | 2000-03-09 |
| NO20010955L (en) | 2001-04-24 |
| AU5810699A (en) | 2000-03-21 |
| EP1105054B1 (en) | 2007-12-12 |
| AU748677B2 (en) | 2002-06-13 |
| DE69937740D1 (en) | 2008-01-24 |
| NO20010955D0 (en) | 2001-02-26 |
| WO2000012016A1 (en) | 2000-03-09 |
| KR20010073020A (en) | 2001-07-31 |
| DE69937740T2 (en) | 2008-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2341704C (en) | Three dimensional, low friction vasoocclusive coil, and method of manufacture | |
| US7316701B2 (en) | Three dimensional, low friction vasoocclusive coil, and method of manufacture | |
| US8790363B2 (en) | Three dimensional, low friction vasoocclusive coil, and method of manufacture | |
| EP1105053B1 (en) | Vasoocclusive coil | |
| US6159165A (en) | Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand | |
| US6168570B1 (en) | Micro-strand cable with enhanced radiopacity | |
| US6241691B1 (en) | Coated superelastic stent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20190827 |